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Infectious disease of equines has significant impacts on the New Zealand 
equine industry, causing avoidable morbidity and mortality. The correct 
identification of the aetiological agents involved in such infections allows 
for prompt and accurate administration of an appropriate therapeutic 
strategy, reducing the economic impact associated with equine wastage.  
 
Traditional culturing methods are widely used for the diagnosis of infections 
in horses, however, conventional PCR offers a novel and rapid approach, 
through the targeting of unique genes for diagnosis of pathogens. PCR is an 
attractive alternative to microbial culturing, which can take anywhere 
between 24 hours to 1 week to determine the causative infectious agent, and 
in a number of cases the results are not as specific or as accurate as they 
need to be. It is the lack of sensitivity of the traditional culturing techniques 
that continues to contribute to the economic loss and welfare issues 
associated with equine infections.  
 
Initially, it was found that an SDS lysis extraction method worked best for 
extraction of DNA which was used to extract microbial DNA from various 
types of clinical samples. These were subsequently used as DNA templates 
within PCR alongside primers associated with up to 28 genes associated 
with common equine infections. From a total 146 clinical samples received 
for testing 66.4% returned a PCR positive for one or more microbial genera, 
whereas traditional bacteriological culturing produced an identification rate 
of 46%. In addition, PCR was significantly faster than culturing methods (6 
hours vs 48 hours) and allowed more specific identification of the microbes 
present, which provides a significant advantage for infection management 
and increasing animal welfare. 
 
The results found from these experiments show rapid PCR identification 
holds promise as a diagnostic technique in the future, however, further 
development is required before this can be used as a primary diagnostic 
technique. Recommendations include further research into trends of 
 
ii 
infection in NZ equines and respectively increasing the diversity of PCR 
primers to represent the larger scope of microbial species. PCR diagnosis 
would also benefit from the standardisation of the DNA extraction methods 
used to allow consistency and increase throughput of various samples. 
Lastly, the simplification of the individual PCRs for each infectious agent 
could be developed into multiplex reactions to decrease time processing 
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1 Chapter One 
INTRODUCTION 
 
There are a number of bacterial and viral diseases New Zealand horses may 
encounter. Understanding the causes and susceptibilities associated with 
microbial disease is important for welfare, successful farming, and to allow 
the most effective treatment. Detecting the causative agent early in infection 
is key to this, and there are a number of methodologies available. However, 
more needs to be done to improve these to allow better detection of 
pathogens within clinical samples.  
 
 
1.1 Effect of disease on the New Zealand equine industry 
The equine sport horse industry contributes over $1 billion to the New 
Zealand economy annually, with the greatest component being the 
thoroughbred sector (IER Pty Ltd., 2010; Matheson & Akoorie, 2012). This 
economic contribution makes the loss of individuals from treatable disease 
and infection an important issue, putting strain on the New Zealand industry 
(Fennessy, 2010; IER Pty Ltd., 2010; Matheson & Akoorie, 2012; Tanner et 
al., 2012). Infections affecting horses can be localised (gastrointestinal or 
respiratory) or become systemic (sepsis), and pose a significant welfare, and 
economic burden through foal crop decline, time wasted in training and 
failure to race, and reduced welfare for infected individuals (Dunowska et 
al., 2002a; Furr, 2003; McKenzie III & Furr, 2001; Sanchez, 2005). 
 
In New Zealand, localised and systemic equine infections contribute 
significantly to wastage in the equine industry. However, compared to 
gastrointestinal and systemic infections, respiratory infections have lower 
rates of mortality (Dunowska et al., 2002a). Nationally and internationally, 
mortality caused by neonatal sepsis causes a great economic loss, through 
lost export. Up to 50% of foals in New Zealand fail to race, contributing 
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significantly to wastage within the industry. (Matheson & Akoorie, 2012; 
Tanner et al., 2012).  
 
 
1.2 Importance of a New Zealand diagnostic scheme  
Illness bought on by infection impacts the performance of sport horses and 
reduces the welfare of all infected horses (Christley et al., 2001; Perkins, 
2005). Due to New Zealand’s geographical isolation and strong biosecurity 
regulations, equine diseases and infectious sources are expected to vary 
from those seen on a global scale (Toombs-Ruane et al., 2016). However 
very little is known about causes and strains of infection, as there is a 
distinct absence of epidemiological studies on New Zealand equine 
infections. Therefore, a reliable diagnostic scheme is needed to begin 
collecting information on the epidemiology of infectious disease, along with 
communication from local veterinarians.  
 
The requirement for specific diagnostic techniques is also being driven by 
the need for New Zealand to be antibiotic free by 2030, where ideally 
antimicrobial treatment will only be applied to infections where the 
pathogenic cause has been identified. In order to achieve responsible 
antimicrobial use by veterinarians, increased detection and diagnostics are 
required to determine the causative organism of infection within a short time 
frame. This will allow the most appropriate therapeutic strategy to be 
determined before antimicrobial treatment is administered (New Zealand 
Veterinary Association, 2016). In addition, the increase in antimicrobial 
resistance is also a driving factor for more accurate diagnostics within a 
veterinary setting in New Zealand. Antimicrobial resistance is a known 
factor that has increased mortality associated with sepsis and other bacterial 
infections within the equine industry (Dunkel & Johns, 2015).  
 
 
1.3 Welfare implications 
Effective diagnosis of infections will help address welfare issues associated 
with sepsis and inadequate treatment. Early recognition of infection in 
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horses followed by the correct diagnosis allows for the application of the 
most effective treatments, as show in studies with septic neonatal foals 
(Fielding & Magdesian, 2015). Identification of the pathogenic species is 
essential for increasing survival rates in critically ill neonates, and it has 
been suggested that appropriate treatment targeting the infectious source 
needs to be administered within three hours of recognising sepsis (Fielding 
& Magdesian, 2015). This critical timeframe, and specificity of infectious 
organisms for treatment, makes the development of a rapid diagnosis system 
critical to reducing mortality caused by infections, such as sepsis, and 
improving the overall clinical prognoses. Rapid diagnosis would not only 
improve the diagnosis and treatment of horse diseases, but would also 
provide economic benefits, and improved welfare of the animals. 
 
 
1.4 Groups of horses susceptible to infections 
Infectious diseases in horses are diverse and can manifest in a variety of 
ways. The manifestation can be detrimental to the welfare of a horse, often 
ending a racing career, or in some cases become fatal, causing the death of 
an animal if left untreated. Factors such as age, immune status, and the 
environment an animal is kept in can leave an individual susceptible to 




There are multiple contributing factors that leave equine neonates 
susceptible to life threatening infections. Factors such as reduced immunity 
and multiple routes of invasion make this group of animals highly 
vulnerable to a variety of infections. Neonatal sepsis is a highly fatal disease 
found in newborn foals and is the leading cause of morbidity and mortality 
in foals under seven days old (Fielding & Magdesian, 2015; Furr, 2003). 
Despite increasing diagnostic and treatment technologies, sepsis remains a 
major cause of mortality in New Zealand horses, causing economic loss and 




Equine neonates are born with minimal immunity, therefore the acquisition 
of immunoglobulins to build immunity is dependent on the ingestion of 
colostrum from the mare during the first 24 hours of life. Failure of passive 
transfer results when a neonate fails to ingest the colostrum and antibodies 
contained within it, causing an increased risk of infection and therefore 
death (Clabough et al., 1991). An experimental study compared the 
acquisition of bacterial infection between colostrum fed and colostrum 
deprived foals (Robinson et al., 1993). With colostrum deficiency treatment, 
62% of foals developed sepsis compared to 0% who were fed colostrum, 
demonstrating the severe impact of colostrum deficiency and its role in 
equine disease.  
 
Another risk factor of infection in neonates relates to the health of the mare, 
as before parturition, blood is shared between the mare and foal. Bacteria 
associated with placental disease can enter the amniotic fluid, gaining access 
to either the respiratory of gastrointestinal tracts of the foetus. Additionally, 
the exposed umbilical stump can become contaminated with bacteria, or 
bacteria can be ingested or inhaled leaving newborns at greater risk of 




The weaning stage in foal development occurs between 6-12 months and 
can cause significant stress to the animal. Changes around this time in 
development include the loss of immunoglobulins, microbiota, and 
immunity from the mother’s milk, changes in the foals environment or 
housing, and increased freedom which may leave young foals at increased 
risk of infection or disease (Heleski et al., 2002; Palmer, 1985). Due to the 
inquisitive nature of young animals, it is observed that there can be an 
increase of microbial infection in foals as a result of ingesting irritating or 
infectious substances (Palmer, 1985).  
 
Weaning is recognised as a stressful event to young horses and as a result 
has been recorded as associated with susceptibility to certain infectious 
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microbes, such as Lawsonia intracellularis, a known gastrointestinal 
pathogen in young horses (Heleski et al., 2002; Page, 2013). Additionally, 
the stress involved with weaning may induce latent Equine herpesvirus 1 
(EHV-1), acquired before partition, or from the environment and other 
animals shedding the virus. This poses a significant risk to young horses, as 
the clinical impact of these infections leave them susceptible to increased 
risk of respiratory infection, particularly when there is no vaccination 
programme implemented (Ostlund, 1993; Pusterla et al., 2009b).  
 
1.4.3 Close quartered animals  
There is high incidence of indirect transmission between individuals, 
particularly with highly virulent or contagious diseases, such as 
Streptococcus equi subspecies equi (Strangles). Indirect transition methods 
occur through fomites, which are objects which carry infection, and include; 
housing, water sources, feed, handlers, and equipment which facilitate the 
transmission of microbes causing disease (Sweeney et al., 2005).  
 
Hygienic housing is extremely important for health regulation in horses, 
specifically to prevent cross infections between different individuals (Mills 
& Clarke, 2007). Some housing, such as boxstalls, leave horses sharing a 
common airspace, which can promote the spread of disease as infected 
animals may shed infectious particles that can affect other horses (Mills & 
Clarke, 2007). Rhodococcus equi, an infectious agent that causes respiratory 
disease in horses, is known to be spread through the air, and results in direct 
transmission in stabled horses via shared air supply (Mills & Clarke, 2007).  
 
Although stabling is not common practice in New Zealand thoroughbred 
horses, the housing of horses can also increase risk of the transmission of 
respiratory diseases, particularly EHV-1, Strangles, and R. equi which are 
spread through horse-to-horse contact, shared equipment, and are 
exacerbated by limited air and housing (Ministry for Primary Industries, 
2014; Muscatello et al., 2009). Stress caused by confinement has also been 
recognised to exacerbate and accelerate the spread of diseases, such as 




1.4.4 Environmental and on farm management 
Bacterial species such as R. equi thrive and multiply within horse faeces, 
particularly in summer months (Giguère & Prescott, 1997). Therefore, the 
removal of faeces from paddocks and shared environments is recommended 
to reduce shedding of disease and infection of animals (Mills & Clarke, 
2007; Prescott, 1991). Other infectious organisms, such as Clostridia 
difficile which is known to survive well in the environment, are often 
resistant to common disinfectants (Båverud, 2002). Because of this, care 
must be taken in hospitals and areas with infected animals to ensure the risk 
of transmission from fomites is reduced.  
 
 
1.5 Systemic infections 
Septicaemia (sepsis) is a prominent disease in the equine community and is 
one of the largest causes of foal crop loss and wastage in the equine 
breeding industry. Sepsis encompasses a broad range of disorders 
originating from a variety of infectious agents, including bacterial, fungal, 
viral or mixed infections, resulting in different clinical presentations and 
prognosis (McKenzie III & Furr, 2001; Wong & Wilkins, 2015). Early 
recognition of sepsis and its microbial cause, along with prompt, accurate, 
and aggressive antimicrobial administration is critical for successful clinical 
outcomes (Fielding & Magdesian, 2015; Taylor, 2015).  
 
1.5.1 Detection 
Sepsis is an exaggerated, systemic inflammatory response to infection and is 
identified by physiological symptoms within an animal. Septic horses will 
commonly present with an abnormal heart rate, blood pressure, and blood 
counts (McKenzie III & Furr, 2001). Current recognition and diagnostic 
techniques through the use of septic scores and bacterial cultures 
demonstrate poor sensitivity, low throughput and slow processing times. 
These diagnostic inadequacies are thought to contribute to an estimated 50% 
of mortality in septic neonates (Fielding & Magdesian, 2015). Overall, the 
 
7 
prognosis for a sepsis diagnosis has been highly variable leading to short 
term survival rates in septic neonatal foals, ranging from 10-70%. However, 
this outcome has improved significantly, likely due to early detection and 
treatment of vulnerable foals and it is now more appropriate to quote a 
prognosis for short-term survival of approximately 50–60% (Taylor, 2015). 
Survival rates in mature horses with sepsis are also shown to vary 
considerably, however it is difficult to prognosticate as no studies have been 
done to evaluate a large population of adult horses with sepsis. 
 
1.5.2 Who is affected? 
Sepsis is predominantly seen in neonates due to their immunocompromised 
status, however, it can affect any age animal if a localised infection 
progresses into the bloodstream (Taylor, 2015). As foals are born with 
limited immunity, the risk factors for the development of neonatal sepsis are 
significantly raised by a number of issues including the foaling environment, 
the health of the mare and the success of normal behaviours following 
parturition. The development of sepsis in neonates has been shown to 
correlate to the failure of passive transfer, which greatly increase the risk of 
sepsis development (McKenzie III & Furr, 2001; Robinson et al., 1993; 
Taylor, 2015). Premature birth and significantly reduced colostrum intake 
increase the risk of infection in foals. Reduced colostrum, which is the 
primary cause of passive transfer failure, accounts for up to 40% of septic 
foals, as colostrum provides pathogen specific immunity and 
immunoglobulins needed for immunocompromised neonates to fight 
potential pathogens (Furr, 2003; Robinson et al., 1993). 
 
1.5.3 Causes of sepsis 
Sepsis is caused by the introduction of pathogens into the bloodstream. 
Microbial infection can occur prenatally (via the mare) or postnatally, 
through infection of the umbilical stump, placenta, secondary wounds, 
ingestion, or inhalation with respiratory routes being the primary routes of 
infection (Furr, 2003). Bacterial infections are the predominant cause of 
sepsis in equine neonates (Taylor, 2015). Worldwide studies have identified 
both Gram negative and Gram positive bacterial isolates that can cause 
 
8 
sepsis. In the past, Gram positive organisms were seen as the most 
ubiquitous sepsis-causing organisms, however, the frequency of infections 
caused by Gram negative bacteria has been increasing (McKenzie III & Furr, 
2001). Horses with Gram negative infections are considered to be at greater 
risk of mortality than those infected with Gram positive bacteria due to 
differences in the morphological, physiological, and virulence factors 
between species. Structural differences mean different antibiotic strategies 
are required for effective treatment (Taylor, 2015). An additional 
complicating factor is the presence of polymicrobial infections, which 
account for up to 50% of sepsis-causing infections, which can easily be 
missed in cultures (Furr, 2003). Lastly, geographical and temporal changes 
to common infectious pathogens also complicates sepsis diagnosis.  
 
Limited information is available surrounding the causes of sepsis infections 
in New Zealand horses. However, in a study of foal sepsis, it was concluded 
in a test of 127 samples that Gram positive bacteria accounted for roughly 
65% of cultured bacteria and Gram negative accounted for 35% (Toombs-
Ruane et al., 2016). The most common bacterial species associated with 
sepsis included Streptococcus spp., Staphylococcus spp., Enterococcus spp. 
and Escherichia coli, which were found in 79% of 127 samples. Globally, 
Streptococcus spp. have been recognised as the most common Gram 
positive bacterial species, and E. coli as the most common Gram negative 
species causing sepsis (Toombs-Ruane et al., 2016). Other Gram positive 
bacteria recognised include; Staphylococcus spp., Enterococcus spp., 
Bacillus spp., R. equi, and Clostridium spp. Frequently identified Gram 
negative isolates include Enterobacter spp., Acinetobacter spp., Klebsiella 
spp., Proteus spp., Citrobacter spp., Pseudomonas spp., Pasteurella spp., 
Salmonella spp. and Serratia spp. (McKenzie III & Furr, 2001; Russell et 
al., 2008; Toombs-Ruane et al., 2016). Although bacteria have been 
recognised as the dominant source of sepsis-causing infections there is also 
evidence of EHV-1 and Equine herpesvirus-4 (EHV-4) causing septic 
infections. EHV-1 has been described as the most frequently occurring viral 
infectious species in neonatal sepsis (McKenzie III and Furr (2001) with 
EHV-4 predominantly causing respiratory infections (Ostlund, 1993). 
Fungal species can also cause infection and disease within horses, with 
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Candida recognised as noted pathogenic species, particularly infecting 
neonates (McKenzie III & Furr, 2001). 
 
1.5.4 Diagnosis 
Bacteriological blood culture and phenotypic analysis of culturing results 
currently provides the most definitive diagnosis of the infectious organism. 
Culturing methods have a substantial processing time, with each taking 
approximately 48-72 hours before a result is obtained (Pusterla et al., 2009a; 
Taylor, 2015). These cultures exhibit low efficiency and poor sensitivity, 
typically giving a culture result 60% of the time, and in case studies 
efficiency has been shown to be as low as 25% (Russell et al., 2008; Taylor, 
2015). This poor sensitivity is exacerbated by a bacterial cultures inability to 
detect viral or fungal infections, and only growing bacteria supported by the 
culture medium. Additionally, false negatives with bacterial cultures are 
reported approximately 12-37% of the time (Furr, 2003; Rieger et al., 2014). 
To overcome this, the use of the sepsis score also accompanies 
bacteriological culture diagnosis, and allows for the recommendation of 
treatment. However, the sepsis score does not provide information on the 
source of infection or the agent causing it. Rapid diagnosis is critical, and it 
has been suggested that a delay of more than 3 hours before administration 
of antimicrobials can increase mortality (Fielding & Magdesian, 2015). 
However, in order to achieve this more effectively, there needs to be a 
physical exam (early recognition of sepsis using the sepsis score) along with 
a more rapid lab diagnosis to confirm the infectious agent (Fielding & 
Magdesian, 2015).  
 
1.5.5 Route of treatment 
Bacterial sepsis is potentially able to be treated successfully through 
appropriate antimicrobial therapy, which requires the correct identification 
of the infection causing microbe. This allows the application of the 
appropriate antimicrobial against the infectious organisms and the correct 
administration method (Furr, 2003). Generalised treatment for septic foals 
currently includes prompt implementation of a combination of broad-
spectrum penicillin based antimicrobials, hemodynamic support, and fluids 
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(Fielding & Magdesian, 2015; Furr, 2003). However, knowing the strain of 
the causative organism is important for determining treatment as infections 
with either Gram positive, Gram negative, or viral organisms make a 
significant difference to treatment and prognosis (Silhavy et al., 2010). 
Additionally, information about the site of infection should also be 
considered in order to determine the best route of drug administration, 
pharmacokinetics and cost of treatment (Furr, 2003; Palmer, 2014).  
 
Antimicrobial susceptibility testing is also becoming an important aspect of 
sepsis, diagnosis and clinical treatment (Fielding & Magdesian, 2015; New 
Zealand Veterinary Association, 2016). ß-lactams, aminoglycosides, 
cephalosporins, or a combination of penicillin and gentamicin are currently 
the first line of treatment in a majority of New Zealand sepsis cases as 81% 
of isolates are recorded as responding to either antimicrobial (Toombs-
Ruane et al., 2016). However, with the rise of antimicrobial resistance 
identified in bacterial isolates in New Zealand foals, care now needs to be 
taken when administering drugs to unknown infections (Toombs-Ruane et 
al., 2016).  
 
 
1.6 Respiratory infections 
Respiratory infections are prevalent among thoroughbred horses and is a 
known contributor to airway infections and inflammation frequently 
observed in racehorses (Hughes, 2013). Respiratory disease is the largest 
cause of wastage in equine industries worldwide and is noted to interfere 
with training (McBrearty et al., 2013). Equine respiratory infections are 
considered multifactorial, normally involving a combination of microbial 
infection, environmental interactions, and host interactions (McBrearty et al., 
2013). Unfortunately, respiratory diseases often go undiagnosed and failure 
of correct diagnosis leads to inappropriate treatment and the absence of 
subsequent preventative measures being undertaken to mitigate the spread 





Respiratory infections are suspected upon detection of characteristic 
symptoms, such as airway inflammation, coughing, and nasal discharge 
(Christley et al., 2001). Unlike sepsis, clinical symptoms can be indicative 
of the pathogen causing infection. Coughing is consistently linked to 
bacterial infections, therefore is an avenue that should be investigated 
(Christley et al., 2001). Viral infections often show serous or mucopurulent 
(mucous and pus) nasal discharge, cough, enlarged retropharyngeal or 
submandibular lymph nodes, and poor performance in training and racing 
(Dunowska et al., 2002a). 
 
1.6.2 Who is affected? 
Lower airway inflammation in thoroughbred horses is seen to occur in 20%-
50% of racehorses in training (Christley et al., 2001). In New Zealand 56% 
of horses presenting with respiratory disease were under 3 years and 11% 
were under 1 year (McBrearty et al., 2013).  
 
1.6.3 Causes of respiratory infection 
Fomites and shared airspace spread respiratory diseases, particularly R. equi 
pneumonia which can be transmitted by breathing, and therefore close 
proximity (Mills & Clarke, 2007; Muscatello et al., 2009). Poor 
environmental management can also cause increased spread of infection as 
R. equi grows rapidly in faeces left within the environment, and oral-faecal 
ingestion is a primary route of R. equi infection (Mills & Clarke, 2007; 
Takai, 1997).  
 
Respiratory diseases are very common among horses globally, and there are 
a number of pathogens known to cause respiratory diseases in horses 
(Dunowska et al., 2002a). In the past, the cause of respiratory disease had 
been associated exclusively with viral infections, however, further 
epidemiological investigations have shown the importance of bacteria as a 
primary pathogen in horse respiratory disease (Christley et al., 2001). 
Pathogenic microbes associated with respiratory disease include bacteria, 
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namely Streptococcus species and viruses, such as equine influenza virus 
and herpesvirus (Christley et al., 2001; Dunowska et al., 2002a). Similar 
pathogens have also been recognised within New Zealand, with R. equi, S. 
equi subspecies equi, S. equi subspecies zooepidemicus, EHV-1 and EHV-4 
recognised as the primary cause of respiratory infection and disease 
(Toombs-Ruane et al., 2015).  
 
i) Equine influenza 
Equine influenza is the prominent respiratory disease in horses worldwide 
and causes significant damage to the equine industries (Cullinane & Newton, 
2013). Caused by an orthomyxovirus of influenza A, equine influenza 
presents itself as the dominant microbe causing respiratory disease in horses 
of many countries (Daly et al., 2011; Timoney, 1996). At present, there is 
no knowledge of equine influenza existing within New Zealand, likely due 
to strict biosecurity and quarantine laws, as well as geographical barriers 
(Cullinane & Newton, 2013; Rosanowski et al., 2012). Equine influenza 
causes clinical symptoms very similar to other respiratory diseases, 
including pyrexia, nasal discharge, and dry coughs, therefore, vaccinations 
and quarantine are widely used to mitigate risk of transmission and 
identification schemes should be rapid in the case of transmission into New 
Zealand (Cullinane & Newton, 2013; Rosanowski et al., 2012).  
 
ii) Equine herpesvirus (EHV) 
Equine herpesvirus are a well characterised group of viruses known to cause 
respiratory disease in horses and cause a significant loss within the horse 
industry on a worldwide scale (Harless & Pusterla, 2006; Varrasso et al., 
2001). The clinically significant EHV-1 and EHV-4 are dominant viral 
infections, affecting horses and are endemic in New Zealand (Ministry for 
Primary Industries, 2014). Currently, Equine herpesviruses are the only 
viruses shown to cause respiratory infection in New Zealand horses 
(McBrearty et al., 2013).  
 
a) EHV-1 
EHV-1 is a common pathogen in horses distributed both worldwide and 
within New Zealand (Dunowska, 2014; Lunn et al., 2009). There are 
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multiple forms of EHV-1, all of which can cause a myriad of symptoms 
ranging from mild to severe respiratory disease, abortion, reduced 
reproductive performance, and neurological disease (Dunowska, 2014; Lunn 
et al., 2009; Ostlund, 1993). Initially EHV-1 infections occur within the 
respiratory tract, targeting the respiratory epithelium before becoming 
established in varying tissue types (Lunn et al., 2009). EHV-1 causes 
sporadic mild respiratory disease in young horses under 2 years and in adult 
horses can cause abortion and outbreaks of equine myeloencephalopathy 
(Lunn et al., 2009).  
 
 
Figure 1.1: Equine abortion caused by suspected Equine herpesvirus infection 
(Photo source: Dr Lee Morris, Equibreed NZ). 
 
Historically, methods for identification of EHV-1 and EHV-4 involved the 
use of virus isolation in cell culture with serological typing (Varrasso et al., 
2001). Due to the clinical importance of both Equine herpesviruses and their 
potential to severely damage the equine industry, there is a drive for rapid 
diagnostic methods. This has been successfully achieved using PCR which 
amplifies regions of the conserved thymidine kinase (TK) and glycoprotein 
B (gpB) genes of the herpesvirus genomes (Carvalho et al., 2000; Varrasso 
et al., 2001).  
 
b) EHV-4 
EHV-4 causes respiratory disease occasionally involved in equine abortion, 
and is indistinguishable from EHV-1 in a clinical setting (Carvalho et al., 
2000; Ostlund, 1993). Epidemiological studies have shown that EHV-4 
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causes significant respiratory disease outbreaks in young racehorses around 
the time of weaning (Ostlund, 1993). EHV-4 has been found to be present in 
40% of all diseased horses presenting respiratory infection and in 0% of 
healthy horses (McBrearty et al., 2013). This is more abundant than EHV-1 
which is found in 6% of all diseased horses presenting respiratory infection 
(also 0% in healthy populations), supporting that EHV-4 is a more abundant 
and causative agent of respiratory infection compared to other herpesviruses. 
 
iii) Streptococcus spp. 
Lower respiratory infections in horses are commonly caused by aerobic 
Streptococcus species, including S. equi subspecies equi, S. equi subspecies 
zooepidemicus, S. dysgalactiae subspecies equisimilis and S. pneumoniae 
(Timoney, 2004; Wood et al., 1993).  
 
a) S. pneumoniae 
S. pneumoniae is a known, yet somewhat uncommon pathogen in horses 
(Blunden et al., 1994; Burrell et al., 1986; Timoney, 2004). It is recognised 
as a cause of respiratory inflammation and infection when found in high 
numbers within the lower respiratory tract, however, it can be found in high 
numbers in horses not presenting any respiratory infection (Burrell et al., 
1986). When seen to be pathogenic, S. pneumoniae is predominantly 
observed in young training racehorses (Timoney, 2004). It is likely to be 
transmitted due to the shedding of bacteria from infected individuals or the 
transmission through handlers and therefore care should be taken during 
outbreaks of infection (Burrell et al., 1986). 
 
b) S. equi subspecies equi 
S. equi subspecies equi is responsible for Strangles which is a highly 
contagious and a severe cause of respiratory disease in horses (Sweeney et 
al., 2005; Timoney, 2004). Strangles affects young horses and is transmitted 
via inhalation or ingestion of the bacterium (Taylor & Wilson, 2006). 
Strangles infections are characterised by abscessation of head and 
submandibular lymph nodes and has a highly variable incubation period of 
4-14 days. This means preventative measures such as isolation of sick 
animals should be undertaken to ensure infection is not spread, as Strangles 
 
15 
transmits very easily with stress and overcrowding (Laus et al., 2007; 
Timoney, 2004). Strangles has a recorded morbidity rate of 100% and a 
mortality of 10%, which highlights the requirement for rapid and accurate 
detection (Laus et al., 2007). Unfortunately, it can be difficult to identify as 
it shows low culture sensitivity when clinical samples are analysed using 
traditional microbial culturing. Recently, better identification has been 
achieved through the use of molecular methods, such as polymerase chain 
reaction (Patty & Cursons, 2014).  
 
c) S. equi subspecies zooepidemicus 
S. equi subspecies zooepidemicus has been strongly associated as a primary 
pathogen in lower airway disease in thoroughbred horses. It causes 
necrotizing legions and pneumonia in mature horses and is associated with 
the clinical symptom of coughing (Christley et al., 2001; Timoney, 2004). 
Infection occurs through inhalation, and S. equi subspecies zooepidemicus is 
seen as a highly opportunistic pathogen, thought to often form concurrent 
infections with viruses, particularly equine influenza (Timoney, 2004).  
 
d) S. dysgalactiae subspecies equisimilis 
S. dysgalactiae subspecies equisimilis is an opportunistic Streptococcus 
species found on the skin and mucous membranes of various animals and 
known to cause infection in horses (Laus et al., 2007; Timoney, 2004). It 
has been suspected to present symptoms similar to Strangles (Laus et al., 
2007), leading to cases being misidentified, however, is generally 
considered a facultative parasite (Laus et al., 2007). 
 
iv) Rhodococcus equi 
R. equi (previously known as Corynebacterium equi) is a known respiratory 
pathogen derived from soil and faeces that causes pneumonia and severe 
infection in horses, particularly in foals (Takai et al., 1991). Abundant 
within soil on horse and stud farms, affected farms are heavily contaminated 
with virulent forms of R. equi (containing VAP A plasmid). Animals are at 
increased risk of infection as R. equi is spread easily through the air in stalls, 
significantly exacerbated on dry and windy days. This weather dependent 
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spread determines why R. equi is also recognised to have a temporal 
prevalence as a respiratory pathogen (Takai, 1997).  
 
Clinical isolates of R. equi are more pathogenic than those acquired from the 
environment due to virulence factors, such as cholesterol oxidase (CHO) 
and phospholipase C exoenzymes (Prescott, 1991). In addition, virulent 
strains contain a 85-90kb plasmid carrying genes for virulence associated 
proteins (VAP), such as VAP A, which specifically cause pneumonia in 
foals, and can be used to differentiate virulent R. equi from harmless 
environmental strains (Muscatello et al., 2009). R. equi infections most 
commonly manifest as pneumonia with lung abcessation and lymphadenitis, 
alongside increased respiratory rate and fever (Giguère & Prescott, 1997; 
Prescott, 1991). Severely affected individuals, predominantly foals less than 
6 months of age, can die as a result of severe and rapid onset infection 
despite treatment, due to early pneumatic pyogranulomas that occur prior to 
respiratory symptoms. However, mortality from R. equi is rare in adult 
horses (Giguère & Prescott, 1997; Prescott, 1991). Exhalation of virulent R. 
equi occurs 65% of the time and is noted to be a major cause of spread and a 
main cause of R. equi pneumonia on farms (Muscatello et al., 2009). 
 
As an intracellular pathogen, R. equi can be difficult to identify as retrieval 
can be difficult from the pyrogranulomas that it forms (Muscatello et al., 
2009). This same intracellular habitat also makes treatment more difficult as 
an in vitro approach is needed, however this is achieved using a 
combination drug approach of erythromycin and rifampin (Båverud, 2002).  
 
v) Fungal infection 
Fungal infections are rare in New Zealand equine disease literature, 
however, have the potential to cause damaging and life-threatening 
respiratory infections (Stewart & Cuming, 2015). Fungal species recognised 
as pathogens in horses include; Cryptococcosis spp., Pseudoallescheriosis 
spp., Aspergillosis spp., Conidiobolomycosis spp., Blastomycosis spp., 
Histoplasmosis spp., Coccidiomycosis spp., Scopulariopsis spp., 
Adiospiromycosis spp., Canndidasis spp., and Epichloe coenophila. Due to 
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their abundance, they need to be considered during diagnosis (Munday et al., 
2017; Pacynska, 2013; Secombe et al., 2017; Stewart & Cuming, 2015). 
 
Fungi are ubiquitous in farm environments, and may be found in soil, feed, 
damp hay, and bedding. They can cause infection as primary pathogens, or 
cause opportunistic infections in immunocompromised horses, such as those 
undergoing treatment using antimicrobials or steroids (Pacynska, 2013; 
Stewart & Cuming, 2015). Fungal infections are predominantly acquired 
through the inhalation of a high level of fungal spores, the inhalation of a 
highly virulent strain, or through fungal penetration into an open wound or 
compromised gastrointestinal tract (Secombe et al., 2017; Stewart & 
Cuming, 2015). Some fungal infections can be directly traced to 
environmental causes such as the relationship between fescue grass infected 
with E. coenophiala causing equine fescue oedema (Munday et al., 2017).  
 
In respiratory infection, fungal pathogens manifest as upper or lower 
respiratory tract infections, often causing pneumonia, rhinitis, meningitis, 
granulomas, and in some cases abortion (Secombe et al., 2017; Stewart & 
Cuming, 2015). Fungal infections often present only as a cough, or poor 
athletic performance, contributing to delayed diagnosis (Stewart & Cuming, 
2015) 
 
Diagnosis involves the use of patient history, clinical presentation, 
diagnostic imaging, histopathology, culture, and cytology of infection 
(Stewart & Cuming, 2015). Traditional diagnostic techniques are limited as 
cytology cannot differentiate the dead and live fungal cells, making it 
difficult to determine whether treatment has been effective or not (Secombe 
et al., 2017). Treatment involves medical intervention with the application 
of pathogen specific drugs, and surgery. Early detection of fungal infections 
is rare, and this contributes significantly toward high mortality rates 





The most significant factor to consider during diagnosis of respiratory 
disease is the bacteria found in the lower airways are frequently part of the 
normal and environmental flora found in the upper airways (Christley et al., 
2001). This shared bacterial load creates a need to carefully interpret any 
diagnostic result, particularly those obtained from cultures (Hughes, 2013).  
 
1.6.5 Route of treatment 
Upon confirmation of infection, appropriate measures must be taken to treat 
the affected animal and reduce the risk of transmission between other 
animals (Sweeney et al., 2005). Treatment is multifaceted, firstly by 
segregation and quarantine of infected animals, then followed by 
appropriate treatment targeting the area of infection specific to cause of 
infection (Sweeney et al., 2005).  
 
Intermuscular administration of ceftiofur sodium and ampicillin sodium has 
been shown to be successful in the treatment of horses with unidentified 
respiratory infections (Folz et al., 1992). The treatment of Strangles 
involves topical and systemic application of benzylpenicillin, and in the case 
of guttural pouch involvement, treatment may also involve the application 
of a topical penicillin gel mixture directly into the infected pouch (Sweeney 
et al., 2005). Long term antimicrobial treatment is needed for long 
term/systemic respiratory infections. 
 
Non-pneumonia respiratory infections caused by Streptococcus species are 
often treated with penicillin as the primary antimicrobial. S. equi isolates are 
also highly susceptible to trimethoprim-sulfadiazine (TMS) in the 
occurrence of penicillin allergy, however, S. zooepidemicus does not 
respond to this, highlighting the importance of the correct identification of 
pathogenic species before treatment (Sweeney et al., 2005). In Strangles 
treatment, resistance is noted with aminoglycosides, particularly gentamicin 




For the treatment of R. equi there are a wide variety of antimicrobial 
treatments, with gentamicin, and ciprofloxacin showing sensitivities over 
95% and low resistance rates (Giguère & Prescott, 1997). The most 
common drug approach for treatment of R. equi infections involves a 
combination of erythromycin and rifampin, which demonstrated 
dramatically reduced mortality in foals since its introduction likely due to 
the combination of erythromycin which penetrates caesous material 
associated with R. equi pyrogranulomas (Giguère & Prescott, 1997).  
 
 
Figure 1.2: Examples of clinical treatment applied to respiratory infection causing 
pleuropneumonia. Application of systemic antibiotics, IV fluids, non-steroidal anti-




1.7 Gastrointestinal infections 
Gastrointestinal disease or enterocolitis is a significant section of equine 
disease and causes significant morbidity and mortality in mature horses and 
foals (Weese et al., 2001). In horses, particularly foals, diarrhoea can occur 
for a number of reasons ranging from foal heat diarrhoea, nutritional 
diarrhoea, ulceration, or microbial infection (Palmer, 1985). This diverse 
distribution of disease causes and symptoms provides a requirement for a 
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thorough understanding of gastrointestinal infections to provide accurate 
diagnosis and treatment. However, diagnosis is often confounded by the 
diversity of the gut microbiota, meaning that the aetiological agent of any 
gastrointestinal infection is only identified in less than 10% of infections 
(Weese et al., 2001).  
 
1.7.1 Detection  
The symptoms of gastrointestinal infection remain similar regardless of the 
aetiological agent of infection, therefore leaving the infectious pathogen 
indistinguishable based on clinical symptoms (Båverud, 2002; Feary & 
Hassel, 2006; Pusterla & Gebhart, 2013). For example, salmonellosis 
presents foul watery diarrhoea, but this factor alone is not significant 
enough to distinguish it from other causes of disease, as infections by C. 
difficile, and other pathogens present similar symptoms (Feary & Hassel, 
2006; Palmer, 1985). Common symptoms of gastrointestinal infection 
include fever, depression, mild abdominal pain, increased heart rate, a 
‘toxic’ mucous membrane and diarrhoea (Palmer, 1985).  
 
 
Figure 1.3: Foal with suspected gastrointestinal infection presenting with acute 




1.7.2 Who is affected? 
Intestinal microbiota is regarded as the first line of defence against 
gastrointestinal infection, as normal flora prevents colonisation of 
pathogenic bacteria (colonization resistance), but disruption to normal flora 
allows potentially pathogenic species to become established within the gut 
and produce toxins, causing disease (Båverud, 2002). Antibiotics in 
particular disrupt the normal bacteria in the gut, and affect the balance of 
protective flora, allowing overgrowth of opportunistic pathogenic species 
known to cause gastrointestinal infection (Diab et al., 2013). Disruption can 
also occur due to changes of feed, which may occur seasonally, during 
weaning, or through the acquisition of microbes or spores from the 
environment, such as bacterial shedding from an infected horse (Palmer, 
1985). Infections such as C. difficile and R. equi can be acquired through 
contaminated soil, faeces, animals, or fomites such as veterinary equipment 
used with sick animals (Diab et al., 2013). Around 70-80% of foals under 
six months old are affected with some form of diarrhoea, which can be 
caused by a multitude of reasons, not just microbial infection (Palmer, 1985). 
In mature horses many infections manifest as a gastrointestinal infection, 
but these are often self-limitating (Palmer, 1985).  
 
1.7.3 Causes of gastrointestinal infection 
A significant cause of diarrhoea in foals is from bacterial infection by 
Salmonella spp., with equine salmonellosis being well documented (Palmer, 
1985). Infection can also be associated with Clostridium spp. such as 
Clostridia perfringens, and C. difficile, however these occur normally in soil 
and the intestinal tract of animals, so are not always diagnostically relevant 
when found within a sample (Båverud, 2002; Palmer, 1985). Due to the 
variation of pathogens seen within gastrointestinal infection, common 
bacterial and viral isolates found associated with disease are discussed 
below.  
 
i) Salmonella spp. 
Salmonellosis infection from Salmonella spp. is a major and serious cause 
of bacterial gastrointestinal infection in horses (Palmer, 1985). Colitis 
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caused by Salmonella spp. causes enterocolitis, which is often associated 
with rapid onset diarrhoea (Feary & Hassel, 2006). Latent Salmonellosis can 
occur as a result of stressors including; transport, gastrointestinal tract 
disorders, changing feed, abdominal surgery, high temperatures and 
antimicrobial therapy (Feary & Hassel, 2006).  
 
ii) Lawsonia intracellularis 
The causative organism of equine proliferative enteropathy (EPE) is 
L. intracellularis, which is a major pathogen in equine gastrointestinal 
disease and causes symptoms similar to many other bacterial infections 
(Frazer, 2008; Pusterla & Gebhart, 2013). Infection occurs post weaning in 
foals aged 3 to 6 months and in young adults and is found as a dominant 
pathogen in horses worldwide (Feary & Hassel, 2006; Pusterla & Gebhart, 
2013). L. intracellularis infections are becoming endemic on farms, 
increasing in frequency and there has been a rise in infections, particularly 
of foals, weanlings and horses under 12 months over recent years (Frazer, 
2008; Pusterla & Gebhart, 2013).  
 
L. intracellularis can infect multiple animal types including pigs, horses, 
and rabbits, and as a consequence exposure to the faeces of these animals is 
known to cause the spread of infection (Pusterla & Gebhart, 2013). Faecal-
oral routes of infection are a dominant cause of the spread of infection and 
coincides with increased infection rates in weanlings as the naive inquisitive 
nature of foals leads them to obtain infectious material (Palmer, 1985; 
Pusterla & Gebhart, 2013). L. intracellularis prognosis is positive with 
accurate diagnosis and prompt treatment, but fatal if not (Feary & Hassel, 
2006). Vaccines may offer the best prevention strategy to mitigate morbidity 
associated with L. intracellularis infection (Pusterla & Gebhart, 2013). 
 
iii) Clostridia spp. 
 
a) Clostridia difficile 
C. difficile is noted as one of the dominant causes of diarrhoea in foals and 
mature horses and associated strongly with antibiotic-associated diarrhoea 
(Båverud, 2002; Diab et al., 2013). The symptoms caused by C. difficile are 
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vague and indistinguishable from many other common gastrointestinal 
pathogens, including other Clostridium and Salmonella spp. (Diab et al., 
2013). C. difficile causes rapid onset diarrhoea, causing high mortality rates 
of up to 42%, particularly in foals (Diab et al., 2013). C. difficile produces 
two toxins, enterotoxin A (C. difficile TcdA) and cytotoxin B (C. difficile 
TcdB), both of which are involved with virulence and can be used as targets 
for identification of infection (Båverud, 2002).  
 
In normal cases, C. difficile is rarely found in faecal samples of adult horses 
(0-1%) and foals (0-3%) and therefore not considered part of the normal 
intestinal flora in adult horses (Feary & Hassel, 2006). However, C. difficile 
is found in abundance within the environment, particularly soils and waters 
(Båverud, 2002). C. difficile is transmitted through ingestion of faecal 
matter or through shared fomites or handlers. Spores survive for long 
periods in the environment and are often resistant to basic disinfectants, 
therefore, surviving months following infection (Båverud, 2002; Diab et al., 
2013). The spread of infection can be reduced by handlers using thorough 
aseptic technique with handlers and care taken with feeding. This is 
particularly important for animals undergoing antibiotic treatment, to 
minimise oral-faecal routes of spore ingestion (Båverud, 2002). Risk factors 
associated with the acquisition of C. difficile infection include 
hospitalisation, and treatment with erythromycin and rifampin, 
trimethoprim/sulfonamids, β-lactam antibiotics, clindamycin and gentamicin 
due to the development of antibiotic associated colitis (Båverud, 2002; Diab 
et al., 2013). Foals under 2 weeks old are highly susceptible to C. difficile 
infection even without prior antibiotic application (Båverud, 2002) and it is 
suspected that colonisation early in life is what causes C. difficile to be a 
dominant cause of gastrointestinal infection in new born horses.  
 
b) Clostridia perfringens 
C. perfringens is associated with enterocolitis in both mature and young 
horses (Feary & Hassel, 2006) and along with C. difficile, are considered the 
major Clostridia species to cause infection in equines. C. perfringens is 
widely distributed within the environment in the form of spores or 
vegetative cells and can be isolated from the faeces of healthy horses (Feary 
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& Hassel, 2006). C. perfringens is often seen to cause enterocolitis in equine 
neonates, due to colonization of the gastrointestinal tract within the first 24-
72 hours postpartum (Feary & Hassel, 2006).  
 
C. perfringens is dividing into multiple strains, type A, B, C, D and E. Type 
C most commonly infects foals (Uzal et al., 2012) and produces the 
virulence factors cytotoxic β-toxin and α-toxins, and is rarely found in the 
environment (Feary & Hassel, 2006). Infections in foals are characterised by 
abdominal pain, fever, and diarrhoea and may progress to sepsis, meaning 
infections can have a mortality rate of 54%-68% even with medical 
intervention (Feary & Hassel, 2006). In mature horses infection presents 
itself less commonly and less aggressively, often caused by Type A, 
commonly found in normal horses along with the β2-cytotoxin (Feary & 
Hassel, 2006). Type A is also known to contain genes for production of C. 
perfringens enterotoxin (CPE) and although the mechanisms of how CPE 
causes symptoms associated with Type A infection is unknown, this gene 
can be exploited by molecular methods for diagnosis (Weese et al., 2001).  
 
It is important to note that there is also suspected interactions between 
Clostridia spp., specifically C. perfringens Type C and C. difficile which 
may further complicate diagnosis and create a need for more thorough 
diagnostic testing, where both can be identified if a polymicrobial infection 
is present (Uzal et al., 2012).  
 
iv) Rotavirus 
Globally, Group A rotaviruses are recognised as a cause of gastrointestinal 
infection within equines, with particular effects seen in foals. Nearly all 
foals under the age of 3 months experience a bout of rotavirus prior to 
weaning and as rotavirus causes between 50%-90% of diarrhoea in foals 
under 3 months, rotavirus is considered the major cause of gastrointestinal 
infections in neonates (Bailey et al., 2013; Papp et al., 2013). Although the 
effects are mild, rotavirus has been known to cause death as a result of 




Rotaviruses are prevalent worldwide, including New Zealand, and 
considered endemic to most horse populations (Bailey et al., 2013). 
Transmission occurs through oral-faecal route and through contaminated 
animals and fomites (Bailey et al., 2013). Vaccination and on farm 
management prevents the spread of rotavirus and significantly decreases the 
infection rates (Papp et al., 2013). The self-limiting nature of rotavirus in 
horses, means it is an infection of least concern, however, it is important to 
correctly identify rotavirus to ensure a more pathogenic and potentially fatal 
microbe is not causing infection (Papp et al., 2013).  
 
v) Rhodococcus equi 
As in respiratory disease, R. equi can be a common cause of gastrointestinal 
infection in horses. It has a temporal prevalence and is recorded to infect 
foals particularly within the summer months, coinciding with foals that are 
0-6 months old (Prescott, 1991). R. equi infection in mature horses is less 
common and can manifest either as a respiratory or gastrointestinal infection, 
where it causes ulcerated lesions within the gut (Giguère & Prescott, 1997; 
Takai, 1997).  
 
Although present worldwide in the soils, R. equi is shed through faeces and 
easily contaminates farms, making faecal shedding a predominant 
mechanism of infection transmission (Takai, 1997). Although normally 
present in soil, R. equi is significantly higher in soil in areas with horses 
(Giguère & Prescott, 1997). Bacterial growth is enhanced 1000x more in 
faeces left in the environment (Giguère & Prescott, 1997), making on farm 
management, such as removal of faeces, an important process in mitigating 
the spread of infection (Takai, 1997). Inhalation and ingestion of R. equi 
through oral-faecal transfer is the infectious route, and R. equi is highly 
opportunistic often affecting young foals with failure of passive transfer 
(Takai, 1997). Ingestion of R. equi infected sputum can also lead to 
ulcerative colitis in foals (Prescott, 1991). 
 
It has been shown that 50% of foals with R. equi respiratory infections can 
also develop R. equi gastrointestinal infection, characterised by intestinal 
lesions. However, only 4% of foals have intestinal lesions without R. equi 
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respiratory infections (Giguère & Prescott, 1997). Diarrhoea may also 
present itself when R. equi respiratory infections are present, due to an 
increase in mucus build-up in the gut (Prescott, 1991). With combined 
treatment using erythromycin and rifampin, survival rates are as high as 
88% (Giguère & Prescott, 1997). Early recognition, passive immunization 
(colostrum), and environmental management reduce the risk of spread and 
initial infection (Giguère & Prescott, 1997).  
 
1.7.4 Diagnosis 
Diagnosis of gastrointestinal infection is difficult due to the complexity of 
the normal gastrointestinal tract flora, and the fact that most infections 
present with clinically indistinguishable features (Båverud, 2002; Feary & 
Hassel, 2006; Pusterla & Gebhart, 2013). The similarity of presentations 
means symptom recognition is difficult and a differential diagnosis 
combining symptoms, serological results, and culturing are often used for a 
confident diagnosis (Pusterla & Gebhart, 2013). Salmonellosis is often 
identified through symptom recognition along with faecal cultures obtained 
from at least five faecal samples (Feary & Hassel, 2006; Palmer, 1985). 
Unfortunately this ‘gold standard’ diagnostic method takes a minimum of 2-
5 days for diagnosis and produces results with less than desirable accuracy, 
only providing a diagnosis 55% of the time (Feary & Hassel, 2006). 
Diagnosis is further confounded by poorly standardised culturing 
methodology between diagnostic laboratories (Feary & Hassel, 2006).  
 
Faecal cultures have in the past been the best diagnostic tool for 
identification of C. difficile. However, following a 48 hour incubation time 
cultures remained less sensitive than molecular tools, with the inability to 
differentiate or identify TcdA and TcdB (Båverud, 2002). Using faecal 
cultures for diagnosis is tedious, as these need to be collected in rectal 
sleeves or bags and maintained aerated during a 36-48 hour incubation 
period (Feary & Hassel, 2006). Additionally, C. difficile strains need to be 
identified rapidly, as within 72 hours of waiting time the sensitivity can 
decrease from 76% to 29% and culture techniques cannot differentiate 
between non-toxigenic and toxigenic C. difficile strains. However, 
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molecular methods such as PCR or enzyme-linked immunosorbent assay 
(ELISA) have the potential for toxin identification and therefore present a 
more accurate approach for diagnosis (Diab et al., 2013). L. intracellularis 
can be identified using post-mortem tissues for histology, although ante 
mortem diagnosis is preferred and can be used with PCR detection of 
L. intracellularis in faeces or rectal swab and/or serology (Pusterla & 
Gebhart, 2013).  
 
1.7.5 Routes of treatment 
Treatment of gastrointestinal infections differ significantly dependant on the 
aetiological agent and is mainly supportive with the application of fluids and 
electrolytes. There is a strong requirement of correct diagnosis of the 
aetiological species, as narrow-spectrum antibiotics provide the best 
treatment in order to treat the pathogenic species while maintaining normal 
gut flora to avoid re-colonization by other opportunistic pathogenic species 
(Feary & Hassel, 2006).  
 
 
1.8 Traditional diagnostic methods  
Traditional diagnostic methods used to identify horse diseases are highly 
variable dependant on the nature of the organism and the site of infection. 
Optimal culturing methods are centred on setting up ideal growth conditions, 
which differ greatly between sample types and microbes. This means many 
different specific conditions are needed in order to identify pathogens within 
a clinical sample. These methods involve bacteriological and 
microbiological culturing followed by phenotypic identification. These 
methods are extremely time consuming and often insufficient, leading to 
misidentification and therefore misdiagnosis in cases such as Strangles and 
S. dysgalactiae subspecies equisimilis (Laus et al., 2007). In addition, 
isolates that had been previously phenotypically identified as R. equi, have 
eventually been reclassified with the introduction of molecular methods. 
These molecular methods have allowed the taxonomic identification of 
distant species, such as S. epidermidis, (Stefańska et al., 2016) suggesting 
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phenotypic identification and culturing may have been misleading in a 
number of cases previously.  
 
1.8.1 Bacterial cultures 
In humans and other animals, blood culture remains the gold standard for 
the diagnosis of septic infections, however these take a minimum of 24-48 
hours to identify (Lehmann et al., 2008). Additionally, culturing can be 
achieved using any serum from the sight of infection, allowing the culturing 
of bacteria found in infected joints, synovial fluid, or pus. Most often, blood 
cultures return negative, leaving the application of correct treatments being 
based only on observational symptoms (Lehmann et al., 2008). At other 
times cultures may return false negatives, which are found to occur 12-37% 
of the time (Furr, 2003; Rieger et al., 2014). Cultures demonstrate poor 
efficiency and low sensitivity, with results only being correctly diagnosed 
60% of the time, with actual case studies showing efficiency to be lower 
than 25% (Russell et al., 2008; Taylor, 2015). False-negatives often occur 
with culture diagnosis due to low levels of bacteria that circulate in 
collected samples (Pusterla et al., 2009a). Good culturing results are very 
dependent on bacterial growth which can be affected and or inhibited by 
storage, preparation and transport conditions (Stefańska et al., 2016). The 
use of antibiotics, before blood is taken also creates a huge hurdle for the 
identification of pathogens with cultures as they will not grow successfully, 
meaning detection of the aetiological agent may be impossible (Mencacci et 
al., 2011).  
 
1.8.2 Viral cultures 
Traditional viral identification methods such as histology and ELISA have 
been found to be time consuming, expensive, and laborious (Carvalho et al., 
2000). Viral detection without molecular techniques has only been 
performed by specialists who compare information on the effect of the virus 
on the host, alongside bio-assays such as neutralisation, fluorescent antibody, 
negative staining, or electron microscopy (Boonham et al., 2014). Similar to 
bacteria, the culturing of viruses also requires multiple cell culture types in 
order to provide optimal growth conditions. A large amount of specialist 
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knowledge is required for viral cultures and the consideration of the clinical 
symptoms provides significant insight for diagnosis, and is therefore used 
heavily to guide culturing conditions (Storch, 2000). During cell growth, 
morphological changes can be indicative of viral species, allowing diagnosis. 
Viral cells can also be tested with fluorescent antibodies or monoclonal 
antibodies specific for suspected viruses. These diagnoses can take 24-48 
hours to culture, and an additional 1-3 weeks for inoculation (Storch, 2000). 
The complications associated with traditional viral diagnostics means they 
are often overlooked as equine pathogens, and can therefore cause otherwise 
avoidable morbidity and mortality. 
 
1.8.3 Fungal cultures 
Fungal cultures are the current gold standard diagnostic techniques for 
fungal infections in animals (Brilhante et al., 2016). Species, such as 
Coccidioides spp. known to affect equines are slow growing and as a result 
may take three to five days to grow before diagnosis is possible (Brilhante et 
al., 2016). The slow growing phase and infrequency of fungal infections 
means these are also often overlooked during diagnosis.  
 
 
1.9 Molecular methods for diagnosis 
Due to the requirement of an accurate diagnosis before the application of 
treatment, determining the aetiological agent of infection is of the utmost 
importance when dealing with sepsis and other infections in equines and 
other animal species (Mencacci et al., 2011). Because of the time sensitivity 
of diagnosis there has been a requirement of a rapid diagnostic strategy for 
equines. Molecular methods are being recognised as more specific and 
sensitive, especially when detecting low levels of microbes within an 
infection (Stefańska et al., 2016).  
 
1.9.1 Polymerase chain reaction (PCR) 
PCR is a widely used diagnostic tool, recognised to demonstrate high 
specificity and sensitivity. PCR uses enzyme replicating methods to 
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replicate small amounts of DNA exponentially within a short time period of 
1-2 hours (Rahman et al., 2013). Applications of PCR are broad and have 
been used in molecular and biomedical research for cloning, DNA 
sequencing and the analysis of genes (Rahman et al., 2013). However, has 
also been applied diagnostically for the detection of infectious diseases and 
cancers. The rapid nature of the PCR protocol allows it to be a rapid method 
for early diagnosis and detection of disease and infection. Diagnostic PCR 
uses small reaction volumes containing DNA template, pathogen specific 
primers, buffers, free nucleotides, and selective enzymes which are then 
cycled between varying optimal temperatures by a thermal cycler (Rahman 
et al., 2013). Desired PCR products can be viewed on agarose gels and 
analysed quickly to determine the success of amplification, indicative of the 
presence of pathogens (Settanni & Corsetti, 2007). 
 
An important component of a PCR reaction is the template DNA which is 
formed by purified or high quality DNA obtained by performing a DNA 
extraction method on a serological sample or tissue. The next critical factor 
are the primers which determine the start and end of the desired region to be 
amplified. Primers are short DNA strands between 18-25bp that are 
designed to gene areas unique to the suspected organisms involved in 
infection. The primers adhere to the DNA template at complimentary 
regions, allowing the DNA to be copied (Rahman et al., 2013). The enzyme 
involved in the amplification of the DNA is also very important and 
involves TAQ polymerases that anneal complementary nucleotides, 
allowing the formation of a new strand, which is initiated by primers 
binding. TAQ polymerase, derived from Thermus aquaticus is a 
thermostable polymerase which is available in different forms (Kralik & 
Ricchi, 2017). Hot-start is the most commonly used TAQ polymerase, 
which uses a thermally activated DNA polymerase enzyme for the 
annealing of nucleotides during PCR. This greatly increases the specificity 
of PCR products while reduces background noise, nonspecific binding, and 
primer dimers which commonly occur during a reaction set up with 
alternative polymerase reagents (Birch, 1996). Hotstart TAQ polymerase is 
activated by a 95°C pre-PCR hold, which can be easily incorporated into a 
regular thermocycling program. The use of this highly specific polymerase 
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in diagnostics is extremely important, as it mitigates non-specific binding 
that may be misinterpreted as a false positive results. Other factors 
important in PCR are the single bases of A, T, C and G deoxynucleotide 
triphosphates (dNTPs), which become incorporated and allow the synthesis 
of the new DNA strands and the PCR buffer which aid in protecting the 
template DNA and creates the optimal conditions for the enzymes activity.  
 
Once reagents are combined, specific temperatures in thermal cycling cause 
PCR to occur, replicating specific gene areas from template DNA. A period 
of 95°C initiates Hotstart TAQ polymerase and denatures double stranded 
template DNA. A lowered temperature of between 50-70°C allows primers 
to adhere to the single stranded template DNA. Lastly, a temperature of 
72°C provides the optimal temperature for the enzymatic activity of the 
TAQ polymerase, which then extends the primers, binding free dNTPs and 
forming amplicons. These temperatures cycle around and exponentially 
replicate the selected gene areas (Figure 1.4). 
 
 
Figure 1.4: Primary steps of PCR; melting, annealing, and extension necessary for 
the successful amplification of target DNA sequence from DNA template (Thermo 




PCR protocols themselves can also be altered to improve amplification 
efficiency, such as incorporating touchdown PCR (TD-PCR), which can 
reduce nonspecific primer annealing through lowering annealing 
temperatures between cycles (Rahman et al., 2013). This is recommended 
when using PCR for diagnostic purposes (Korbie & Mattick, 2008). The 
melting temperature of a primer is determined by the composition of 
oligonucleotides and helps to calculate an expected annealing temperature 
of the primers being used. However, the simplified method of calculating 
Tm is limited due to additional factors, including the arrangement of 
nucleotides and buffers used within a reaction. As a result, PCR will always 
require optimisation with each new set of primers in order to determine 
optimal Tm, which can be achieved in combination with TD-PCR (Korbie 
& Mattick, 2008). TD-PCR approach begins with a temperature above the 
calculated Tm and gradually lowers following each cycle. This helps to 
compensate for miscalculations in the annealing temperature, resulting in 
higher quality amplicons (Korbie & Mattick, 2008; Yamamoto, 2002).  
 
Multiplex PCR is another modification that allows multiple primer sets to be 
used to identify multiple microbes in a single PCR reaction. It builds on 
traditional PCR for the detection of multiple microbial species by containing 
a pool of primers that allow the simultaneous amplification of multiple gene 
areas in a single reaction (Settanni & Corsetti, 2007). This offers a useful 
strategy to identify multiple infectious isolates rapidly, with ease and at a 
lower cost (Elnifro et al., 2000). The simultaneous amplification of multiple 
target genes within a reaction is achieved through the addition of multiple 
primer sets and adjustments to buffers and other reaction components. To 
develop this, the expected primer size and Tm must be considered, and 
careful optimisation is critical for reliability of results (Elnifro et al., 2000). 
Amplified products can then subsequently be analysed on a high density 
agarose gel using electrophoresis (Settanni & Corsetti, 2007).  
 
1.9.2 Quantitative PCR (qPCR) 
qPCR is another variation on traditional PCR, which has become an 
established diagnostic method within human and veterinary medicine. qPCR 
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monitors DNA amplification during a PCR reaction, by measuring 
fluorescence following each cycle. A fluorescent protein is included in the 
PCR reaction, which will intercalate between double stranded DNA that is 
formed at the end of each elongation cycle. Using a laser, the fluorescent 
protein is excited, and the fluorescent signal generated allows an accurate 
quantification of the DNA that has been amplified, providing a quantitative 
result when compared to a reference for control. This approach mitigates the 
need to completely wait for the PCR to finish and to run the products out on 
an agarose gel to visualise and determine successful amplification (Kralik & 
Ricchi, 2017). Florescent detection within a qPCR can be achieved using 
either non-specific fluorescent DNA dyes or fluorescently labelled 
oligonucleotides. Similar to traditional PCR, it is possible to design a qPCR 
protocol for every pathogenic microorganism, through the design of primers. 
Also, due to the high through-put, speed of amplification, and result analysis 
qPCR offers a unique method for pathogen detection with clinical samples. 
However, still requires optimisation, particularly when using a multiplex 
approach (Kralik & Ricchi, 2017). 
 
A limitation with any PCR approach is the methodology cannot differentiate 
between live and dead cells, which may lead to false positives by amplifying 
genes for organisms not responsible for the current infection (Kralik & 
Ricchi, 2017). 
 
1.9.3 Enzyme-linked immunosorbent assay (ELISA) 
Enzyme-linked immunosorbent assay (ELISA) is an additional molecular 
technique that has applications in the diagnosis and detection of microbial 
infections. ELISA uses serological samples to measure antibodies associated 
with disease and infection, and has wide uses in human and veterinary 
diagnosis though its potential use as mass screening assays. Some microbial 
species with proteins present on the surface of the bacteria allow for the 
identification via ELISA. ELISA utilises immunoassays to detect the 
presence of an antigen or antibody in a sample, binding or attachment of the 
antibody or antigen to the assay causes an interaction that can be measured 
as a colour change for detection. ELISA have been applied to the detection 
 
34 
of select viruses and bacterial infections in equines and other animal species 
(Prescott et al., 1996). Unfortunately these were recognised to have the 
potential to cross-react and produce false positives (Prescott et al., 1996).  
 
ELISA is considered alongside PCR to be a successfully established virus 
detection method, allowing for increased assay sensitivity with monoclonal 
antibodies, high specificity, and high versatility with testing sample types 
(Boonham et al., 2014). ELISA is an extremely useful tool in diagnostic 
medicine due to its speed, ease of use, and sensitivity compared to 
traditional culture based identification methods (Kralik & Ricchi, 2017).  
 
1.9.4 Efficacy of molecular methods 
The efficacy of PCR diagnosis has been shown to differ depending on 
sample types, showing high accuracy with control samples and lowered 
accuracy with real clinical samples, but has been proven to be more 
sensitive than blood cultures, particularly when antibiotics have already 
been administered (Mencacci et al., 2011). Although PCR is sensitive, 
qPCR has been shown to have higher sensitivity and a reduction in 
carryover of contamination which may result in false positives (Pusterla & 
Gebhart, 2013). ELISA has the potential to be a highly effective molecular 
technique for detecting certain pathogens, particularly in terms of rapid 
diagnosis and can mitigate the requirement of a wet lab, however, does face 
challenges associated with lowered sensitivity (Kralik & Ricchi, 2017).  
 
 
1.10 Use of PCR in diagnostics 
PCR is a molecular method that offers a unique approach for the detection 
of infectious organisms present in the blood stream, tissue, fluid or 
environment of an infected organism. All PCR requires is an extracted DNA 
sample and primers specifically designed to amplify a particular gene region 
unique to a particular pathogen to act as a marker for diagnosis. Currently 





1.10.1 PCR for sepsis identification 
In human clinical samples, qPCR has been used for the rapid diagnosis and 
identification of bacterial pathogens within the blood stream. PCR 
amplification of DNA extracted from whole blood has been tested within 
human samples and has been shown to have a greater accuracy compared to 
traditional culturing methods (Lehmann et al., 2008). By using universal 
16S and 23S ribosomal RNA (rRNA) sequences of bacteria and the 18S and 
5.8S rRNA of fungi target sequences, 25 important human microbial 
pathogens were able to be amplified using PCR and visualised for diagnosis, 
even following serial dilutions of the pathogen (Lehmann et al., 2008). PCR 
can also detect microbial pathogens in other samples, such as synovial fluids 
and purulent exudates, having a higher sensitivity compared to traditional 
culturing methods, even with multiple sample types (Mencacci et al., 2011). 
 
PCR has also been applied to the veterinary setting for the detection of 
bacteraemia in neonatal foals (Pusterla et al., 2009a). With a small panel of 
potential pathogens tested, it was possible to detect pathogens relevant to 
the disease profile with no cross-reactivity and increased speed and 
accuracy (Pusterla et al., 2009a).  
 
1.10.2 PCR for respiratory diseases 
In horses, EHV-1 and EHV-4 are closely related, making it difficult to 
distinguish between the two species using typical serological methods 
(Carvalho et al., 2000). PCR has been used to increase the sensitivity of 
EHV diagnosis and enable the identification of EHV-1 and EHV-4 
infections (Carvalho et al., 2000). Further studies have confirmed the 
sensitivity of PCR for virus detection compared to cultures in a study that 
showed EHV-4 was only identified in 4/21 (19.05%) samples using viral 
isolation, whereas 14/21 (66.67%) was identified using PCR (McBrearty et 
al., 2013). 
 
PCR has also proved more sensitive than cultures for the identification of 
Strangles allowing for the rapid identification of infectious respiratory 
disease causing pathogens (Patty & Cursons, 2014). In addition, PCR 
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technology has been successfully applied to the identification of R. equi 
from various respiratory samples including; tracheal washes, nasal swabs, 
and tissue samples. All of which were amplified with higher sensitivity than 
those using traditional culturing methods (Stefańska et al., 2016). 
 
1.10.3 PCR for gastrointestinal diseases 
A confounding factor in the diagnosis of gastrointestinal disease is related to 
the shedding of bacterial cells or spores from the infected animal. As 
bacterial shedding may not be constant, multiple faecal samples are required 
in order to obtain a sufficient amount of bacterial cells to culture and 
confirm a diagnosis (Feary & Hassel, 2006). PCR has been optimised for 
the detection of gastrointestinal infections, such as Salmonella spp. and 
shown to have higher sensitivity when detecting low numbers, which is 
common during early infection and with irregular bacterial shedding. Low 
numbers like these are often undetectable with traditional culturing methods 
(Feary & Hassel, 2006). Additional work has demonstrated PCR was a 
sensitive method for detecting the presence of L. intracellularis within a 
sample, however, caution was still required with diagnosis, as the presence 
of L. intracellularis did not imply it was the causative agent of the 




Molecular approaches, such as PCR offer a unique approach for the 
detection of pathogenic DNA in multiple clinical samples from equines with 
infections. PCR is highly sensitive, and therefore provides significant 
diagnostic value for the detection of microorganisms for samples that may 
be difficult to culture in vitro (Yamamoto, 2002). Techniques, such as 
multiplexing primers into a single PCR reaction also offer a more rapid and 
sophisticated method for the simultaneous identification of multiple 
organisms, allowing large scale diagnostics to be achieved, which is useful 
within a diagnostic laboratory (Yamazaki-Matsune et al., 2007). PCR 
diagnostics has the potential to overcome limitations of traditional culturing 




This investigation aims to utilise the molecular method of PCR, and exploit 
gene regions unique to major equine pathogens, recognised in previous 
literature to prove the efficacy of PCR as a standalone diagnostic method. 
This project will measure the efficiency of using PCR with clinical samples 
from multiple infection types and begin to provide valuable information on 






2 Chapter Two 
METHODS AND MATERIALS 
 
All experimental work for this project was undertaken in the Molecular 
genetics laboratory, part of the Faculty of Science and Engineering, 
University of Waikato, Hamilton, NZ.  
 
Glassware for media and solutions was vigorously washed using a 
laboratory glassware-grade dishwasher (Miele Professiona, G7893) prior to 
use. Routinely work spaces were disinfected, and were wiped down with 
70% ethanol before work commenced to minimise microbial contamination, 
and cross contamination between samples. PCR reactions were prepared in a 
dedicated ESCO PCR cabinet to minimise the incorporation of DNases and 
cross contamination of samples.  
 
Chemicals were obtained from Sigma-Aldrich (NZ) unless stated otherwise. 
Centrifugation steps were undertaken in a Biofuge pico Heraeus centrifuge 
and incubation steps in a 1.5ml Thermomixer comfort (Eppendorf). PCR 
reactions were carried out in a T100 thermocycler (BioRad). Molecular 
weight ladders used were provided by Genscript and Solis BioDyne. 
Agarose gel electrophoresis was carried out using a dedicated OWL 
electrophoresis tank (ThermoFisher Scientific) containing 1x Super Buffer 
(See Appendix 1) and a LighteningVolt 250P-OSL electrophoresis machine 
(Biolab scientific).  
 
 
2.1 Obtaining ethical approval 
Ethical approval was not required, as the collection of samples by 
veterinarians were part of normal animal husbandry process and a 





2.2 Determining prevalent species 
Communications with NZ equine veterinarian, Dr Angela Hawker (BVSc 
(Dist) MACVSc) and research into NZ veterinary literature was used to 
determine common isolates seen to cause diseases within NZ horses (Table 
2.1). The estimated prevalence of pathogens determined helped to decide 
which microorganisms to focus on and guided primer design.  
 
 
Table 2.1: An example showing the culture results of bacterial species found in 
blood samples of septic neonatal foals in New Zealand (Toombs-Ruane et al., 
2016), which helped direct primer design. 
Species Frequency (%) Gram +/- 
Streptococcus spp.  25 + 
Staphylococcus spp. 24 + 
Enterococcus spp. 9 + 
Escherichia coli 20 - 
Bacillus spp.  
21 
+ 
Rhodococcus equi  + 
Corynebacterium spp.  + 
Micrococcus spp.  + 
Klebsiella spp.  - 
Enterobacter spp.  - 
Acinetobacter spp. - 
Morexella spp. - 




Specimens were collected by veterinarians from around the Greater Waikato 
Region and around Auckland and sent through to the University of Waikato 
Molecular genetics laboratory by post. Specimen types provided included; 
blood sample (in an EDTA tube), blood cultures, abscess material, nasal 
swabs, nasopharyngeal swabs, tracheal wash, faecal swabs, and faecal 
samples. Samples received were categorised into three groups; sterile, 




Samples which should be free from microbial cells in a non-infected animal 
were considered sterile, this included blood, blood cultures, pus, and 
synovial fluid. Sterile samples were retrieved aseptically, with veterinarians 
instructed to clip and scrub the site of infection wearing sterile gloves before 
inserting a sterile catheter and drawing the sample into a sterile syringe 
using a sterile needle. Once drawn, samples were placed into an EDTA tube 
and capped before being stored at room temperature. Some blood samples 
were directly injected into a BD BACTEC™ blood culture media bottle 
before delivery. 
 
Respiratory samples included nasal swabs, nasopharyngeal swabs, and 
tracheal washes. Nasal swabs were retrieved by inserting a sterile swab as 
far as possible into the nasal cavity using a gloved hand, swabbing before 
removing the swab while trying to avoid the external nares, and placing the 
swab back into the sterile container for storage and transport. 
Nasopharyngeal swabs were collected by passing a 40cm cotton tipped 
swab at least 15cm into the nasopharynx and allowing secretions to absorb 
into the swab. Swabs were then cut and placed into a sterile pot containing 
sterile saline for transport and storage (University of Kentucky-Veterinary 
Diagnostic Laboratory, 2017). Tracheal wash samples were obtained using 
sterile saline, following common transtracheal wash procedure methodology, 
and stored in a sterile pot for transport and storage (Animal Health 
Diagnostic Center, 2016).   
 
Gastrointestinal samples included faecal samples and faecal swabs, as well 
as DNA that had been extracted from previous faecal samples in a previous 
study. Faecal samples were retrieved by using a gloved hand to swab or 
scoop a small amount of fresh faeces from the affected animal into a sterile 
pot. 
 
All clinical samples were assigned an identification number to maintain 
anonymity. Sample identification (Sample ID) was assigned based on 
sample type; Sterile (S), Respiratory (R), and Gastrointestinal (G), and 
numbers were assigned based on the chronological reception of samples. All 
 
42 
specimens were stored at room temperature (RT) until extraction, however 
any remaining blood was frozen at -20°C for future tests. 
 
2.4 Bacteriological culturing and identification 
2.4.1 Bacteriological culturing from blood samples 
After inverting the EDTA blood sample, 250-1000µl was aseptically added 
to a 50ml culture flask containing 20ml Columbia broth (See Appendix 1) 
and placed into a culturing CO2 incubator at 37°C (inCu safe, IR SENSOR) 
over night.  
 
2.4.2 Bacteriological culturing streaking 
Incubated cultures were streaked out onto a sheep blood agar plate (See 
Appendix 1) using a sterile 5µl inoculation loop. Single colony streaking 
was achieved (Figure 2.1) by starting at point A and using the inoculation 
loop to spread the culture solution back and forward across a 1/5th section of 
the plate around five times before rotating the plate and repeating at point B 
and rotating again and repeating at point C. Following this, the loop was 
heated and cooled before rotating the plate and repeating the streaking 
procedure at point D. Again the inoculation loop was sterilised using a 
Bunsen burner flame and cooled before forming a single colony streak 
(point E) by moving the loop from the far end of the D streaking section, 
and bringing the colonies into the middle of the plate. The lid of the plate 
was replaced before incubating lid side down at 37°C overnight. Some 
culture samples were additionally streaked onto an amikacin treated blood 




Figure 2.1: Single colony streaking directions. 
 
 
2.4.3 Gram stain from culture media and single colony 
A Gram stain pen (Securline®) was used to mark a 1cm diameter circle on a 
microscopic slide (Fronine). For Gram stain test being performed on a 
single colony, 20µl of sterile water was placed within the marked circle and 
a single colony was emulsified into the water. For Gram stain tests being 
performed on a culture, then 5µl of culture was transferred from the flask 
into the marked area. The culture was heat fixed onto the slide using a 
Bunsen burner and allowed to cool. Crystal violet was applied to the slide, 
ensuring all heat fixed material was immersed and allowed to sit for 1 
minute, following which the crystal violet was rinsed off using tap water 
and a paper towel used to blot around the slide and remove excess water. 
Gram’s iodine was then applied, fully immersing all culture material and 
left to sit for 1 minute. The Gram’s iodine was then rinsed off with tap water 
and subsequently rinsed with 95% ethanol until the ethanol running off the 
side was clear. The slide was blotted with a clean paper towel before dilute 
carbol fuchsin was applied over the cultured material and allowed to sit for 
1 minute. Slides were then rinsed under running water, blotted dry and 
allow to dry fully in a 37°C incubator (Precision, Economy Incubator). 
Gram staining was visualised using a CP-ACHROMAT oil immersion 100x 
lens (Zeiss axiostar) and analysed by observing microbial colony size, shape, 
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bunching, and Gram staining. Gram stain pictures were acquired and stored 
as .jpeg files by photography using either a COOLPIX 4500 camera (Nikon, 
Japan) or Olympus DP30 camera.  
 
2.4.4 Identification of bacteria 
Identification of bacteria was performed by observing morphological 
characteristics of cultured bacteria. Growth characteristics noted included; 
turbid appearance in culture, non/haemolytic growth on blood agar, and 
Gram positive, Gram negative, or polymicrobial appearance following 
Gram staining. Individual colonies were extracted from plates, DNA 




2.5 Specimen processing and DNA isolation 
All samples received underwent genomic and bacterial DNA extraction and 
subsequent PCR diagnosis using selected primers designed to identify 
selected microorganisms. Before all DNA extraction commenced, work 
benches were thoroughly cleaned with 70% ethanol to prevent 
contamination between samples. A thermomixer was preheated to 95°C and 
10% CTAB was place in an incubator at 80°C to liquefy. 
 
2.5.1 Microbial DNA extraction from equine blood using SDS 
lysis 
To ensure microbes were consistently found within samples the blood was 
mixed by inverting the EDTA tube by hand and 200µl of blood was 
aseptically removed from the EDTA tube using a 1.5ml sterile transfer 
pipette (Sarstedt). This was placed into a DNase/RNase free 2ml 
microcentrifuge tube (MULTIMax™) to which 800µl of 1% SDS lysis 
solution (See Appendix 1) was added to lyse the blood and bacterial cells, 
and mixed using a transfer pipette. This solution was placed into a 
thermomixer at 95°C for 10 minutes to agitate at 650rpm and heat the 
sample, promoting an even lysis of the cells. Following this the sample was 
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removed and thermomixer temperature was reduced to 65°C. The solution 
was left to cool for 5 minutes before adding 1ml of pH8 phenol (Sigma) and 
placing on a rotating wheel (Stuart SB2 rotator) to gently mix for 10 
minutes. The solution was subsequently centrifuged at 16,060g for 10 
minutes and the supernatant was carefully removed using a fine tipped 
1.5ml sterile transfer pipette (Sarstedt) and dispensed in a DNase/RNase 
free 2ml microcentrifuge tube (MULTIMax™) before discarding the 
organic phenol layer. To the supernatant, 100µl of liquefied 10% CTAB was 
added and was placed in a 65°C thermomixer for 10 minutes and mixed at 
650rpm. Following this incubation, 750µl of chloroform was added to the 
solution and shaken vigorously by hand for 20 seconds before being 
centrifuged for 10 minutes at 16,060g. Following centrifugation the 
supernatant was transferred into a DNase/RNase free 1.5ml microcentrifuge 
tube using a 1.5ml sterile fine tipped transfer pipette (Sarstedt) and 
precipitated using equal parts of isopropanol (approximately 500µl). The 
microcentrifuge tube was then placed into a spark free freezer (Lec Medical, 
Rollex) at -20°C for between 20 minutes or overnight to allow DNA 
precipitation. After sufficient precipitation the microcentrifuge tube was 
centrifuged at 16,060g for 10 minutes to form a pellet on the side of the tube. 
Isopropanol was gently poured off and discarded and 1ml of 70% ethanol 
was added to the tube to wash the pellet and remove excess salts. This 
ethanol solution was centrifuged at 16,060g for 5 minutes before being 
carefully discarded from the tube without disturbing the pellet. The 
microcentrifuge tube containing the DNA pellet was left open in a fume 
hood for 5 minutes to evaporate any excess ethanol for maximum purity. 
Once thoroughly dried 50µl of TE buffer (10mM Tris 1mM EDTA) was 
added and the tube was briefly vortexed to resuspend the pellet. Extracted 
DNA was then labelled and stored at RT for quantification and use as a 
template for PCR. 
 
2.5.2 Microbial DNA extraction from equine blood using GITC 
To ensure microbes were consistently found within samples the blood was 
mixed by inverting the EDTA tube by hand and 250µl of blood was 
aseptically removed from the EDTA using a 1.5ml sterile transfer pipette 
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(Sarstedt) into a DNase/RNase free 2ml microcentrifuge tube 
(MULTIMax™) to which 750µl of GITC viral extraction mix solution (See 
Appendix 1) was added and placed in a thermomixer at 80°C for 10 minutes 
at 650rpm. Following this 1ml of isopropanol was added and the tube was 
inverted 10 times and then centrifuged immediately at 16,060g for 10 
minutes. Following centrifugation the supernatant was discarded and the 
sample briefly centrifuged again for 10 seconds to ensure removal of 
residual liquid. The precipitate was then dissolved in 350µl of 1% SDS lysis 
solution (See Appendix 1), 350µl 5M LiCl, and 85µL 10% CTAB and 
placed in a thermomixer at 65°C for 10 minutes at 650rpm. Following this 
incubation 750µl of chloroform was added to the solution and shaken 
vigorously by hand for 20 seconds before being centrifuged for 10 minutes 
at 16,060g. Following centrifugation the supernatant was transferred into a 
new DNase/RNase free microcentrifuge tube (MULTIMax™) using a 1.5ml 
sterile fine tipped transfer pipette (Sarstedt) and precipitated using equal 
parts of isopropanol (approximately 500µl). The microcentrifuge tube was 
then placed into a spark free freezer (Lec Medical, Rollex) at -20°C for 
between 20 minutes or overnight to allow DNA precipitation. After 
sufficient precipitation the microcentrifuge tube was centrifuged at 16,060g 
for 10 minutes to form a pellet on the side of the tube. Isopropanol was 
gently poured off and discarded and 1ml of 70% ethanol was added to the 
tube to wash the pellet and remove excess salts. This ethanol solution was 
centrifuged at 16,060g for 5 minutes before being carefully discarded from 
the tube without disturbing the pellet. The microcentrifuge tube containing 
the DNA pellet was left open in a fume hood for 5 minutes to evaporate any 
excess ethanol for maximum purity. Once thoroughly dried 50µl of TE 
buffer (10mM Tris 1mM EDTA) was added and the tube was briefly 
vortexed to resuspend the pellet. Extracted DNA was then labelled and 
stored at RT for quantification and use as a template for PCR. 
 
 
2.5.3 Microbial DNA extraction from pus (abscess) 
For pus, a 1.5ml sterile transfer pipette (Sarstedt) was used to combine 
100µl of pus with 350µl of 1% SDS lysis solution (See Appendix 1) in a 
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DNase/RNase free 2ml microcentrifuge tube (MULTIMax™) and mixed 
thoroughly with a transfer pipette. The tube was placed into a thermomixer 
at 95°C for 10 minutes at 650rpm. Following this the sample was aliquoted 
into two new DNase/RNase free 2ml microcentrifuge tube (MULTIMax™) 
for balance and 350µl of 5M LiCl and 100µl of 10% CTAB added to each 
tube which were then placed into a thermomixer at 65°C and 650rpm for 10 
minutes. For swabs, the cotton section was snapped into a DNase/RNase 
free 1.5ml microcentrifuge tube (MULTIMax™) containing 350µl of 1% 
SDS lysis solution (See Appendix 1) and placed in a thermomixer at 95°C 
for 10 minutes at 650rpm. Following incubation, the swab was removed and 
350µl of 5M LiCl and 100µl of 10% CTAB was added to the tube which 
was then placed in a thermomixer at 65°C and 650rpm rotation for 10 
minutes.  
 
After lysis, 750µl chloroform was added to each tube and shaken for 20 
seconds before centrifuging at 16,060g for 10 minutes. The supernatant was 
transferred into a new DNase/RNase free 1.5ml microcentrifuge tube 
(MULTIMax™) using a 1.5ml sterile fine tipped transfer pipette (Sarstedt) 
and precipitated using an equal volume of isopropanol (approximately 
500µl). The microcentrifuge tube was then placed into a spark free freezer 
(Lec Medical, Rollex) at -20°C for between 20 minutes or overnight to 
allow DNA to precipitate. After sufficient precipitation the microcentrifuge 
tube was centrifuged at 16,060g for 10 minutes to form a pellet on the side 
of the tube. The isopropanol was gently poured off and discarded and 1ml of 
70% ethanol was added to the tube to wash the pellet and remove excess 
salts. This ethanol solution was centrifuged at 16,060g for 5 minutes before 
being carefully discarded from the tube without disturbing the pellet. The 
microcentrifuge tube containing the DNA pellet was left open in a fume 
hood for 5 minutes to evaporate any excess ethanol for maximum purity. 
Once thoroughly dried 50µl of TE buffer (10mM Tris 1mM EDTA) was 
added and the tube was briefly vortexed to resuspend the pellet. Extracted 
DNA was then labelled and stored at RT for quantification and use as a 





2.5.4 Microbial DNA extraction from gastrointestinal sample 
For faecal samples arriving in a pot, a sterile swab was dipped into pot to 
collect faecal matter. The cotton part of the swab would then be snapped off 
into a DNase/RNase free 1.5ml microcentrifuge tube (MULTIMax™), 
500µl of Plant CTAB (see Appendix 1) was added and vortexed for 10 
seconds to thoroughly mix into solution. Plant CTAB (containing DIECA) 
was used at this step to inhibit phenoloxidase from plant matter that may 
have downstream inhibitory effects during PCR. The microcentrifuge tube 
was then placed into 95°C thermomixer at 650rpm for 10 minutes. 
Following incubation the swab was removed using sterile tweezers and 
discarded, and 500µl of phenol chloroform added to the solution before 
being shaken and left on a rotating wheel (Stuart SB2 rotator) for 10 
minutes. This solution was then spun down in a microcentrifuge at 16,060g 
for 10 minutes, following this the supernatant was transferred to a new 
DNase/RNase free 1.5ml microcentrifuge tube (MULTIMax™) using a fine 
tipped 1.5ml sterile transfer pipette (Sarstedt) and precipitated using equal 
parts Na isopropanol to limit PCR inhibitors (see Appendix 1) and again, 
centrifuged at 16,060g for 10 minutes before supernatant and dregs were 
removed. To the pellet, 350µl of 1% SDS lysis solution (See Appendix 1), 
350µl of 5M LiCl, and 100µL of 10% CTAB were added and vortexed for 
10 seconds before placing in a thermomixer for 10 minutes at 65°C and 
650rpm mixing speed. After mixing, 750µl chloroform was added to the 
solution and shaken for 20 seconds before centrifuging at 16,060g for 10 
minutes. The supernatant was transferred into a new DNase/RNase free 
1.5ml microcentrifuge tube (MULTIMax™) using a fine tipped 1.5ml 
sterile transfer pipette (Sarstedt) and precipitated using an equal volume of 
isopropanol. The microcentrifuge tube was then placed into a spark free 
freezer (Lec Medical, Rollex) at -20°C for between 20 minutes or overnight 
to allow DNA to flocculate. After sufficient precipitation the 
microcentrifuge tube was centrifuged at 16,060g for 10 minutes to form a 
pellet on the side of the tube. The isopropanol was gently poured off and 
discarded and 1ml of 70% ethanol was added to the tube to wash the pellet 
and remove excess salts. This ethanol solution was centrifuged at 16,060g 
for 5 minutes before being carefully discarded from the tube without 
disturbing the pellet. The microcentrifuge tube containing the DNA pellet 
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was left open in a fume hood for 5 minutes to evaporate any excess ethanol 
for maximum purity. Once thoroughly dried 50µl of TE buffer (10mM Tris 
1mM EDTA) was added and the tube was briefly vortexed to resuspend the 
pellet. Extracted DNA was then labelled with sample name and stored at RT 
for use as a template for PCR. 
 
 
2.5.5 Microbial DNA extraction from respiratory sample 
For respiratory samples in the form of a nasal or nasopharyngeal swabs, the 
respiratory swab was removed from agar casing and the cotton part was 
snapped into a clean DNase/RNase free 1.5ml microcentrifuge tube 
(MULTIMax™) containing 400µl of sterile 0.85% saline and vortexed for 
10 seconds. Using ethanol and flame sterilized tweezers the swab was 
flipped over in the tube so the cotton was above the level of saline and 
centrifuged at 16,060g for 2 minutes to allow any remaining fluid to leave 
the swab. Sterile tweezers were used to remove and discard the swab and 
the saline solution was vortexed for 10 seconds to resuspend solid material 
into solution. For respiratory samples in the form of a nasal wash or saline 
from around a large swab the tube or pot the solution and swab was in was 
vortexed for 20 seconds and 1.5ml of saline was transferred into a 
DNase/RNase free 1.5ml microcentrifuge tube (MULTIMax™). 
 
Saline solution from either swab or wash samples were then centrifuged at 
16,060g for 10 minutes and saline supernatant was removed leaving a pellet 
in the microcentrifuge tube. This pellet was then resuspended in 350µl of 
1% SDS lysis solution (See Appendix 1), 350µl of 5M LiCl, and 100µl of 
10% CTAB and vortexed for 10 seconds before placing in a thermomixer at 
65°C for 10 minutes at 650rpm. To this solution, 750µl chloroform was 
added and shaken for 20 seconds before centrifuging at 16,060g for 10 
minutes. The supernatant was then transferred into a new DNase/RNase free 
1.5ml microcentrifuge tube (MULTIMax™) using a fine tipped 1.5ml 
sterile transfer pipette (Sarstedt) and precipitated using an equal volume of 
isopropanol (approximately 500µl). The microcentrifuge tube was then 
placed into a spark free freezer (Lec Medical, Rollex) at -20°C for between 
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20 minutes or overnight to allow DNA to precipitate. After sufficient 
precipitation the microcentrifuge tube was centrifuged at 16,060g for 10 
minutes to form a pellet on the side of the tube. The isopropanol was gently 
poured off and discarded and 1ml of 70% ethanol was added to the tube to 
wash the pellet and remove excess salts. This ethanol solution was 
centrifuged at 16,060g for 5 minutes before being carefully discarded from 
the tube without disturbing the pellet. The microcentrifuge tube containing 
the DNA pellet was left open in a fume hood for 5 minutes to evaporate any 
excess ethanol for maximum purity. Once thoroughly dried 50µl of TE 
buffer (10mM Tris 1mM EDTA) was added and the tube was briefly 
vortexed to resuspend the pellet. Extracted DNA was then labelled and 
stored at RT for quantification and use as a template for PCR. 
 
 
2.5.6 DNA extraction from cultured bacteria 
For bacteria grown in media, culture flasks were gently swirled to resuspend 
microbes and a sterile transfer pipette or a syringe and needle were used to 
remove 1.5ml of culture broth and place solution into a DNase/RNase free 
1.5ml microcentrifuge tube (MULTIMax™) which was then centrifuged at 
16,060g for 10 minutes. The supernatant was removed and pellet 
resuspended in 350µL of 1% SDS lysis solution (See Appendix 1), the tube 
was then placed in a thermomixer at 95°C at 650rpm rotation for 10 minutes. 
For bacteria grown on plates, a single colony was selected from the agar 
growth medium using a sterile metal inoculation loop to ensure the 
extraction will only obtain DNA from one organism and placed in 350µl of 
1% SDS lysis solution (See Appendix 1) in a DNase/RNase free 1.5ml 
microcentrifuge tube (MULTIMax™) and placed in a thermomixer at 95°C 
at 650rpm rotation for 10 minutes. 
 
After incubation in lysis solution, 350µl of 5M LiCl and 100µl of 10% 
CTAB was added to each microcentrifuge tube which were then placed in a 
thermomixer at 65°C and 650rpm rotation for 10 minutes. After mixing, 
750µl chloroform was added to the solution and shaken for 20 seconds 
before centrifuging at 16,060g for 10 minutes. The supernatant was 
 
51 
transferred into a new DNase/RNase free 1.5ml microcentrifuge tube 
(MULTIMax™) using a fine tipped 1.5ml sterile transfer pipette (Sarstedt) 
and precipitated using an equal volume of isopropanol (approximately 
500µl). The microcentrifuge tube is then placed into a spark free freezer 
(Lec Medical, Rollex) at -20°C for between 20 minutes or overnight to 
allow DNA to precipitate. After sufficient precipitation the microcentrifuge 
tube was centrifuged at 16,060g for 10 minutes to form a pellet on the side 
of the tube. The isopropanol was gently poured off and discarded and 1ml of 
70% ethanol was added to the tube to wash the pellet and remove excess 
salts. This ethanol solution was centrifuged at 16,060g for 5 minutes before 
being carefully discarded from the tube without disturbing the pellet. The 
microcentriduge containing the DNA pellet was left open in a fume hood for 
5 minutes to evaporate any excess ethanol for maximum purity. Once 
thoroughly dried 50µl of TE buffer (10mM Tris 1mM EDTA) was added 
and the tube was briefly vortexed to resuspend the pellet. Extracted DNA 




2.5.7 Analysis and quantification of genomic DNA  
A Thermo Scientific NanoDrop™ 2000 spectrophotometer was used to 
measure the purity and quantity of extracted DNA. To blank the 
spectrophotometer, 2µl of TE buffer (10mM Tris 1mM EDTA) was placed 
on the clean NanoDrop pedestal. Next, 2µl of extracted DNA resuspended 
in TE buffer (10mM Tris 1mM EDTA) was placed onto the pedestal for 
quantification. DNA quantity was measured in ng/µl and absorbance ratios 
at 260nm/280nm and 260nm/230nm were determined, which were 
indicative of purity. Samples with 260nm/280nm ratios between 1.8 and 2.0 
and samples with 260nm/230nm rations between 2.0 and 2.2 were accepted 
as of sufficient quality indicating little to no contamination from proteins, or 





2.6 PCR setup 
2.6.1 PCR primers 
Primers used within this project were determined from previous papers, 
purchased from Sigma Alrich or IDT, and made up to manufacturer’s 
instructions (See Appendix 2). A primer catalogue for each sample group 
has been generated including forward (F) and reverse (R) sequences, 
approximate PCR product size, and where the primers have been published 
(Table 2.2, Table 2.3, Table 2.4). Primers were chosen to target unique 
genus specific, species specific, or pathogenic genes present in microbial 







Table 2.2: PCR primers used for identifying microorganisms within sterile grouped samples. PCR primers highlighted were used against all samples.  




Gram positive 16S rRNA 
F (DG74) AGGAGGTGATCCAACCGCA 
370 (Klausegger et al., 1999) 
R (p143) GAYGACGTCAARTCMTCATGC 
Gram negative 16S rRNA 
F (785F) AGGAGGTGATCCAACCGCA  
370 (Klausegger et al., 1999) 




F (TStaG422) GGCCGTGTTGAACGTGGTCAAATCA 
370 (Martineau et al., 1996) 




F (SPA F) CAGCAAACCATGCAGATGCTA 
101 (Nakagawa et al., 2005) 




F (Str1) GTACAGTTGCTTCAGGACGTATC 
761 (Picard et al., 2004) 
R (Str2)  ACGTTCGATTTCATCACGTTG 
Escherichia coli uidA 
F (UidA F)  TGGTAATTACCGACGAAAACGGC 
162 (Bej et al., 1991) 




F (lacZ3 F) TGGAAAATGGTCTGCTGCTG 
234 (Molina et al., 2015) 





F (PA-GS F) GACGGGTGAGTAATGCCTA 
618 (Spilker et al., 2004) 
R (PA-GS-R)  CACTGGTGTTCCTTCCTATA 
Bacillus (species) 16S rRNA 
F (463 F) CTAAAACTCAAAGGAATTGACG 
463 (Kadyan et al., 2013) 





F (Ent1) TACTGACAAACCATTCATGATG 
112 (Ke et al., 1999) 
R (Ent2) AACTTCGTCACCAACGCGAAC 
Panfungal species ITS 
F (ITS1d) TCCGTAGGTGAACCTGCGG 
848 
(Clara Gutierrez Galhardo et 
al., 2008) R (ITS4d) CCTCCGCTTATTGATATGC 










herpesvirus-1 R (EHV-1.R) CCGTGAAGTTTCTCCCAAGG 
Thymidine 
Kinase 
F (TkF4) CCTTGGTTCCTTTGGCGAC GCAC 
226-268 (Carvalho et al., 2000) 




F (EHV-4.F) TTACAAAACTCTATGCGCTCCTC 
269 (Hu et al., 2014) 
R (EHV-4.R) TAGGTGCTGATCACTTCGATTTCA 
Thymidine 
Kinase 
F (TkF5) TTGGGCCGTGGCCGAAAAC 
333 (Carvalho et al., 2000) 




F (CHO-F) GCTCGCTTCCAGTTCAATTC 
191 (Cursons, 2017) 




F (VapAF) GACTCTTCACAAGACGGT 
200 (Ocampo-Sosa et al., 2007) 





F (PvapAF) GAGCAAGCGATACCGCCGG 
286 (Ocampo-Sosa et al., 2007) 





F (PvapBF) TGCGATAGCCACAGCCGCT 
477 (Ocampo-Sosa et al., 2007) 




gene TraA  
F (TraA-F1) AGAGTTCATGCGTGACAACG 
959 (Ocampo-Sosa et al., 2007) 






Table 2.3: PCR primers used for identifying microorganisms within respiratory grouped samples. PCR primers highlighted were used 
against all samples. 




16S 16S rRna 
F (16SF) GGATTAGATACCCBBGTAGTCC 
410 (Boye et al., 1999) 
R (16SR) GACGTCRTCCNCDCCTTCCTC 
S. zooepidemicus sorD 
F (F3) ATGGCCTCTGAGGCAGG 
220 
(Kinoshita et al., 




F (eqsim) TCAAATCGGTTGGCACAGAC 
279 (Preziuso et al., 2010) 
R (eqsim) CGTCCTTAGCATAGAAGGATTGG 
S. equi Superantigenic toxin 
F (seelF) GAAGGTCCGCCATTTTCAGGTAGTTTG 
520 (Alber et al., 2004) 
R (seelR) GCATACTCTCTCTGTCACCATGTCCTG 
S. zooepidemicus Putative sortase 
F (srtz) GCTGACTGATCAAGCCACAA 
217 (Patty, 2012) 
R (srtz) AACTGATCGTGTTCCCAAGC 
S. equi equi eqbE 
F (eqbE F) GATGCTTTCAGGGGATTGGA 
342 (Patty, 2017) 




F (EHV-1.F) GGGAAAGCCGGCATCATC 
326 (Hu et al., 2014) 
R (EHV-1.R) CCGTGAAGTTTCTCCCAAGG 
Thymidine Kinase 
F (TkF4) CCTTGGTTCCTTTGGCGAC GCAC 
226-268 (Carvalho et al., 2000) 




F (EHV-4.F) TTACAAAACTCTATGCGCTCCTC 
269 (Hu et al., 2014) 
R (EHV-4.R) TAGGTGCTGATCACTTCGATTTCA 
Thymidine Kinase 
F (TkF5) TTGGGCCGTGGCCGAAAAC 
333 (Carvalho et al., 2000) 




F (CHO-F) GCTCGCTTCCAGTTCAATTC 
191 (Cursons, 2017) 










VAP Virulence plasmid A 
F (VapAF) GACTCTTCACAAGACGGT 
200 
(Ocampo-Sosa et al., 




F (PvapAF) GAGCAAGCGATACCGCCGG 
286 
(Ocampo-Sosa et al., 




F (PvapBF) TGCGATAGCCACAGCCGCT 
477 
(Ocampo-Sosa et al., 
2007) R (PABR) CTGGATATGGCCGAGGAAGC 
TraA 
Conjugal plasmid 
transfer gene TraA   
F (TraA-F1) AGAGTTCATGCGTGACAACG 
959 
(Ocampo-Sosa et al., 







Table 2.4: PCR primers used for identifying microorganisms within gastrointestinal grouped samples. PCR primers highlighted were used 
against all samples.  
Microbe Gene target 
Primer 
name 




16S 16S rRna 
F (p201) GAGGAAGGIGIGGAIGACGT 
201 (Tseng et al., 2003) 
R (DG74) AGGAGGTGATCCAACCGCA 
Salmonella 
(Genus) 











F (aaL-F) TCTGCTGCCATTGTGACTCT 
195-329 
(Wattanaphansak et al., 
2010) R (aaL-R) CTCTCAAGTGGTCCTCGCTG 
TcdA Enterotoxin A 
F (tcdA F) GGTAATAATTCAAAAGCGGCT 
201 (Luna et al., 2011) 
R (tcdA R) AGCATCCGTATTAGCAGGTG 
TcdB Cytotoxin B 
F (398CLDs) GAAAGTCCAAGTTTACGCTCAAT 
177 





Phospolipase C of 
C. sordellii 
F (CSP-09F) TGGGATGATTGGGATTATTCAG 
176 (Bhatnagar et al., 2012) 
R (CSP-09R) TCAGTTCCTGCATATTCATTGT 
C. perfringens 
Phospolipase C of 
C. perfringens 
F (PL3-F) AAGTTACCTTTGCTGCATAATCCC 
283 (Bhatnagar et al., 2012) 
R (PL7-BR)  ATAGATACTCCATATCATCCTGCT 
C. perfringens CPE 
F (CPE-F)  GGTTCATTAATTCAAACTGGTG 
 154 (Cursons, 2017)  
 R (CPE-R) AACGCCAATCATATAAATTACAGC 
C. perfringens netF 
F (net-F) AACAATATGTACAGGTATAACT 
862 (Prescott et al., 2016) 




F (CHO-F) GCTCGCTTCCAGTTCAATTC 
191 (Cursons, 2017) 
R (CHO-R) AGCGGGTGGTATGTGAAGTC 






Microbe Gene target 
Primer 
name 








F (PvapAF) GAGCAAGCGATACCGCCGG 
286 
(Ocampo-Sosa et al., 




F (PvapBF) TGCGATAGCCACAGCCGCT 
477 
(Ocampo-Sosa et al., 
2007) R (PABR) CTGGATATGGCCGAGGAAGC 
TraA 
Conjugal plasmid 
transfer gene TraA  
F (TraA-F1) AGAGTTCATGCGTGACAACG 
959 
(Ocampo-Sosa et al., 







2.6.2 PCR reaction set up  
Either a PCR containing one set of primers (uniplex) or multiple sets of 
primers (multiplex) was used for identifying microorganisms in the clinical 
samples received. All PCRs were made up in a dedicated DNAse free hood 
(ESCO). For most uniplex PCRs, in a 300µl volume PCR tube (Axygen® 
unless otherwise stated), 200µl of 2mM master mix (Table A2.1), 1µl of 
Solis BioDyne Hot FIREPol® DNA polymerase, and 4µl of a mixture of 
forward and reverse primer (10µl of forward, 10µl of reverse, and 80µl TE 
stored at 4°C) was combined (Table 2.5). Primers were at 20mM 
concentration unless otherwise stated. The reagents were gently mixed using 
a sterile pipette and 25µl aliquoted into eight separate PCR tubes. PCR 
mixes were stored at -20°C until required for diagnosis. To each tube 1µl of 
template (100ng/µl concentration) was added. This uniplex PCR setup was 
used for identification of Staphylococcus genus, S. aureus, E. coli, 
Coliforms, Bacillus genus, Pseudomonas genus, Enterococcus genus, 
Panfungal, EHV-1, EHV-4, R. equi (CHO, VAP, VapA, VapB, TraA), L. 
intracellularis, C. sordellii, and C. perfringens (PLC, CPE).  
 
Table 2.5: PCR set up for all uniplex reactions. 
PCR set up for uniplex reactions 
200µl 2mM master mix 
4µl F & R primer mix (each at 20µM) 
1µl Hot FIREPol® Taq polymerase 
 
For the uniplex PCR carried out for the identification of Gram positive and 
Gram negative microbes, the Taq polymerase required sterilization to 
reduce unspecialized amplification. The same setup was used (Table 2.5), 
except 2µl of ethidium monoazide bromide was also added before 
aliquotting 25µl into clear PCR tubes (MULTIMAX™) with the UV hood 
lights off. These clear tubes were subsequently placed in a dark cabinet for 
10 minutes to bind any endogenous DNA and prevent amplification, and 





inactivate the ethidium monoazide bromide. PCR mixes were stored at -
20°C until required for diagnosis. 
 
For the multiplex PCRs carried out to identify multiple microorganisms in 
each reaction, each PCR was made up in a dedicated DNAse free hood 
(ESCO). Depending on the multiplex being used, various amounts of 2mM 
master mix (Table A2.1) or 4mM master mix (Table A2.2) were used, 
along with 1µl of Solis BioDyne Hot FIREPol® DNA polymerase and 
different combinations of primers (Table 2.6 to Table 2.10). 
 
Table 2.6: PCR set up for respiratory multiplex A. 
Respiratory Multiplex A 
184µl 4Mm master mix Expected amplicon size 
6µl  seel (equi) F & R (10µM each) 520bp 
3µl soda (equi/zoo) F & R (10µM each) 235bp 
3µl Equisim (equisimilis) F & R (10µM each) 279bp 
2µl 16S F & R (20uM each) 410bp 
2µl Hot FIREPol® Taq polymerase  
 
Table 2.7: PCR set up for respiratory multiplex B. 
Respiratory Multiplex B 
187µl 2mM master mix Expected amplicon size 
6µl EqbE (equi) F & R (10µM each) 324bp 
6µl sorD (zoo) F & R (10µM each) 220bp 
1µl Hot FIREPol® Taq polymerase  
 
Table 2.8: PCR set up for respiratory multiplex C. 
Respiratory Multiplex C 
194µl 2mM master mix Expected amplicon size 
4µl EHV-1 F & R (20µM each)  326bp 
1µl EHV-4 F & R (20µM each)  269bp 






Table 2.9: PCR set up for Salmonella spp. multiplex. 
16S Salmonella Multiplex 
200µl 2mM master mix Expected amplicon size 
4µl 16S Faecal F & R (20µM each) 400bp 
4µl SiiA (Salmonella) F & R (20µM each) 132bp 
1µl Hot FIREPol® Taq polymerase  
 
Table 2.10: PCR set up for C. difficile multiplex. 
C. difficile Multiplex 
200µl 2mM master mix Expected amplicon size 
4µl C. difficile Tox A F & R (20µM each) 201bp 
4µl C. difficile Tox B F & R (20µM each) 177bp 
1µl Hot FIREPol® Taq polymerase  
 
 
Table 2.11: PCR cycling conditions for sterile and gastrointestinal samples 
(Excluding EHV-1 and EHV-4). 
Lid at 105°C 
1. 95°C 15 minutes 
2. 95°C 15 seconds 
3. 60°C 15 seconds (-1°C per cycle) 
4. 72°C 45 seconds 
5. Go to step 2 (10x) 
6. 95°C 15 seconds 
7. 50°C 15 seconds 
8. 72°C 45 seconds 
9. Go to step 6 (35x) 






Table 2.12: PCR cycling conditions for respiratory samples (Including EHV-1 and 
EHV-4) 
Lid at 105°C 
1. 95°C 15 minutes 
2. 95°C 15 seconds 
3. 65°C 15 seconds (-1°C per cycle) 
4. 72°C 20 seconds 
5. Go to step 2 (10x) 
6. 95°C 15 seconds 
7. 55°C 15 seconds 
8. 72°C 20 seconds 
9. Go to step 6 (35x) 
10. 72°C 5 minutes 
 
 
2.6.3 Visualising results 
2.6.3.1 Gel electrophoresis 
Following PCR, 10µl of each PCR product were mixed via pipette with 2µl 
6x loading dye (See Appendix 1) and loaded into a 2% agarose gel 
(HydraGene LE Agarose) made with 1x Super Buffer (See Appendix 1) 
with a final concentration of 0.00075mg/mL EtBr. Samples were run 
together with 2.5µl of a Solis BioDyne 100bp molecular weight ladder (See 
Appendix 1) or 10µl of a Genscript 100bp molecular weight ladder (See 
Appendix 1). The gel was run in a dedicated OWL electrophoresis tank 
(ThermoFisher Scientific) containing 1x Super Buffer (See Appendix) with 
a LighteningVolt OSP250-L power supply at 200V and 500mA for 15 
minutes at room temperature. The gel was viewed using a TFX-35M GIBC 
UV transilluminator (ThermoFisher Scientific) and imaged as a .TIFF file 






2.6.3.2 Restriction digest 
For the confirmation of EHV-1 and EHV-4 using the specific gpB primers, 
a restriction digest was required, where HincII (New England Biolabs) was 
used to cut EHV-1 and HindIII (Boehringer Mannheim, Germany) used to 
cut EHV-4. To achieve this, 10µl of PCR products were transferred into a 
new PCR tube and 1µl of the required restriction enzyme added. This was 
then incubated at 37°C for 4-12 hours with a DNA engine peltier thermal 
cycler (BioRad). Confirmation of successful enzyme cutting was measured 
using gel electrophoresis with a 2% Super Buffer gel at 200V for 15 minutes 
and visualised using a UV transilluminator, as mentioned above.  
 
2.6.3.3 Quantification of amplified DNA 
DNA quantification was calculated by estimating the band intensity in the 
gel by eye. The brightness of each PCR product band was compared to the 
known DNA concentrations of the Genscript or Solis BioDyne ladder 
(Figure A1.1 and Figure A1.2).   
 
 
2.6.4 Preparation of samples for DNA sequencing and 
sequencing analysis 
2.6.4.1 PCR purification for optimal sequencing results 
To 15µl of PCR product, 1µl of Fast AP shrimp alkaline phosphatase 
(Roche, Germany) and 0.5µL of exonuclease (Roche, Germany) were added. 
Each tube was then placed into a BioRad T100 thermocycler and incubated 
at 37°C for 15 minutes, followed by 85°C for 15 minutes. Once complete, 
samples were prepared for sending to either the Waikato DNA Sequencing 
Facility (Hamilton, NZ) or the Massey University Genome services 






2.6.4.2 Waikato DNA Sequencing Facility 
Following ExoSap samples were sent to Waikato DNA Sequencing Facility 
(Hamilton, NZ). Forward and reverse primers were diluted to 5pmol/µl in 
TE, the template concentration was reported in ng/µl using gel estimate 
quantification method, and PCR product size was reported from known and 
expected bp length. These details were critical for successful sequencing 
reactions in order to get consensus sequences that could be used to 
determine the accuracy of primers. Waikato DNA Sequencing Facility uses 
dye chain terminator sequencing through Applied Biosystems 3130xl 
Genetic Analyser and BigDye Terminator 3.1 reaction mix (ThermoFisher 
Scientific). 
 
2.6.4.3 Massey University Genome Service (Palmerston North, NZ)  
Following purification, PCR product were diluted to 2.5ng for every 100bp, 
following the table from Massey University Genome Service (Table 2.11). 
After dilution, 1µl of each sample was placed into two PCR tubes (labelled 
forward and reverse). Primers were diluted to 4pmol by diluting 1µl of 
200pmol in 50µl of TE buffer (10mM Tris 1mM EDTA). To the respective 
labelled tube, 1µl of diluted forward or reverse primer was added and each 
were topped up with 18µl of double distilled water, making the final volume 
the 20µl. Samples were analysed using ABI3730 DNA with BigDye 
Terminator 3.1 reaction mix (ThermoFisher Scientific). 
 






(in final volume) 
Primer Total 
Quantity  
















2.6.4.4 Analysis of PCR product sequencing 
ABI files received from either Waikato DNA Sequencing Facility or 
Massey Genome Services were opened in Geneious (Geneious® 7.1.8, 
Biomatters Limited). Sequences were trimmed to remove areas of low 
quality from each the forward and the reverse sequence. The forward and 
reverse sequences were then aligned using a pairwise global alignment with 
free end gaps (gap open penalty of 12 and gap extension penalty of 3). 
These aligned sequences were then used to search nucleotide databases 
using basic local alignment search tool (BLAST) found at the National 
Center for Biotechnology Information (NCBI) or the DNA Databank Japan 
(DDBJ). BLAST engines were used to carry out blastn through NCBI 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi) and DDBJ 
(http://blast.ddbj.nig.ac.jp/). Results allowed the accuracy of primers to be 
determined, if the search returned a high quality match to the species that 
was primed for then it was considered to be of sufficient quality to be used 
as a primer for future PCRs. Additionally, BLAST allowed the pathogenic 
species at a species level to be determined, that would otherwise be 





3 Chapter Three 
RESULTS 
 
Results presented are from molecular and traditional methodologies used to 
identify the cause of infection in horses, and measure their efficacy. In 
addition, sequencing was carried out to assess and to confirm the sensitivity 
and reliability of primers used in the identification of infectious microbes.  
 
Clinical samples (n=146) were obtained for this study and DNA was 
isolated from them for the detection of pathogens. Results from these 
experiments have been divided into three major groups for analysis. Sterile 
samples, which include blood, pus, and synovial fluids retrieved aseptically 
from sites that would normally have no microbes present in healthy animals. 
Respiratory samples, which includes nasal swabs, washes and saline from 
around stored nasal swabs. Gastrointestinal samples, which includes faecal 
samples, faecal swabs and 50 randomised DNA samples that had been 
submitted for previous gastrointestinal tests were revisited. Lastly, culture 
samples which included samples received as a culture or samples cultured in 
Columbia broth overnight. These were streaked on a blood agar plate, and 
observed for growth and morphological characteristics of the microbes.  
 
Age groups were divided based on stages of development and estimated 





Table 3.1: Age classifications of equine samples. Used to analyse infection trends 
associated with age or developmental stage.  
Age Group Age 
Newborn Birth – 1 week 
Neonate 1 - 4 weeks 
Foal 1 - 3 months 
Weanling 3 - 12 months 
Yearling 1 -2 years 
2+ 2+ years 
N/A No age data available 
 
The success of the PCR positive results obtained were determined by 
comparing amplicon size to a 100bp ladder and ensuring concurrence 
between expected PCR amplicon sizes determined and primer information 
and design. Selected amplicons of the correct size were also submitted for 






3.1 Culture results 
Selected sterile samples were cultured on blood agar and underwent more traditional diagnostic approaches to determine the identity of the 
microorganisms within the clinical samples (Table 3.2). 
Table 3.2: Culture results from Columbia Broth growth, Gram staining, and morphological growth characteristics on blood agar. 
Sample 
ID Culture details 








S001 No growth N/A N/A N/A N/A N/A 
S002 
Grown and streaked on blood agar. Colonies appear slightly 
haemolytic suggesting Staphylococcus. DNA extracted from 




Blood culture grew coagulase negative Staphylococcus species. 
Extracted single colony proved difficult to lyse for DNA 
extraction. + - N/A N/A 
Coagulase negative 
Staphylococcus spp. 
S005 Did not grow - possibly anaerobic. N/A N/A N/A N/A N/A 
S008 
Culture grew readily on blood agar with teardrop colonies 
(suggest Gram negative species). Gram stain showed cocci and 
potential rods, colonies were successfully extracted and amplified. 
Culture was streaked on an amikacin plate and grew 
Staphylococcus. + + N/A N/A Staphylococcus spp. 




Gram stain showed single small Gram positive cocci. Unable to 
grow on plates. + - N/A N/A 
Unidentified Gram 
positive cocci 









ID Culture details 









Culture grew readily on blood agar and amikacin plates. Culture 
Gram stained and showed Gram positive cocci.  Following this 
DNA was extracted from each plate and underwent PCR. + + N/A N/A Staphylococcus spp. 
S014 
Culture grown from infected knee joint and coffin showed small, 




Didn't properly grow. Gram stain was unclear (large pink blobs, 




A 24 hour culture failed to change turbidity to indicate growth, 
and subsequent Gram stain was negative. Following a longer 
incubation culture flask had scummy growth around top which 
when Gram stained showed Gram positive cocci. DNA was 
extracted from scum and PCR results showed positive bands for 
R. equi, Staphylococcus spp, and S. aureus. The material was re-
streaked onto a blood agar, and the following day was observed to 
be growing a pure haemolytic species, a single colony was Gram 
stained and showed Gram positive cocci. + - + - Staphylococcus spp. 
S022 
Culture initially failed to grow in BacTech culture media 
(Provided by veterinarian) due to antibiotic application. Culture 
material was removed from BacTech and placed into Columbia 
broth overnight where it readily grew a significant colony of 





3.2 Gram stain results 
Example of gram stain results from culture material that help to illustrate the 
morphological characteristics of bacteria and stain colour that were used to 
identify the types of microbes present at 100x oil immersion (Figure 3.1 – 
Figure 3.4).  
 
Figure 3.1: S016 Gram positive cocci. 
 
 
Figure 3.2: S023 Gram positive. 
 
 
Figure 3.3: R042 Gram negative cocci.  
 
Figure 3.4: R039 Gram positive rods 





3.3 Comparison of blood DNA isolation methods   
Initial samples were run in tandem to compare different DNA extraction 
methods. A spectrophotometer was used to determine the efficiency of 
extraction methods by observing the purity and yield of DNA obtained. On 
average, the SDS lysis extraction method worked best and had increased 
DNA yields compared to the GITC extraction method (Figure 3.5). DNA 
purity measured by the NanoDrop™ 2000 also showed the SDS lysis 
extraction method had absorbance ratios at 260nm/280nm and 
260nm/230nm which indicated little contamination. Samples with 
260nm/280nm ratios between 1.8 and 2.0 and 260nm/230nm ratios between 
2.0 and 2.2 were accepted as sufficient quality indicating little to no 
contamination from proteins or solvents used in the DNA extraction process.  
 
 
Figure 3.5: Spectrophotometer results comparing the GITC and SDS lysis DNA 
extraction methods. DNA quantity was established in ng/µl and measured 






3.4 Sterile sample microbe identification 
Sterile samples were obtained from veterinarians within the Greater Waikato Region and around Auckland, New Zealand which had 
information on the age group and clinical details that presented (Table 3.3). Each of these samples had the DNA extracted and were screened 
by PCR to determine which microbial species or genus returned positive. 
 




























































































































S001 Newborn N/A - - - - + - - - - - - - - - - 
S002 Newborn Low immunoglobulin G initially, cyanotic, 
hypovolemic collapsed with sudden onset 
diarrhoea  
+ - + - - - - - - - - - - - - 
S003 Newborn Mare's placenta thick and red. Foal weak 
and did not suckle. Dilated pupils which 
were non-responsive to light. Treated, bottle 
fed, antibiotic treatment. At 2 days foal 
became weaker, white blood count 
decreased. Mare had come from Australia 
where they had a few chlamydial abortions. 
Swab from mare's uterus grew 
Streptococcus spp. and E. coli 

































































































































S004 Newborn Meconium stained placentitis + + + - - - - - + - - - - - - 
S005 Newborn 2 weeks overdue, small dummy foal + + - - - + + - - - - - - - - 
S006 N/A N/A + - + + + - - - - - - - - - - 
S007 Newborn Mare toxic/intestinal (caesarean)  + + + + - - - - - - - - - - - 
S008 N/A N/A + + + - + + + + + - - - - - - 
S009 Newborn Diarrhoea + + - - - - - - - - - - - - - 
S010 N/A N/A + + - - - - - - - - - - - - - 
S011 N/A N/A + - + - - + + - - - - - - - - 
S012 Newborn Septic joints - + - - - - + - - + - - - - - 
S013 Foal Right front pastern swollen. Horse lame and 
febrile. NSFm radiographs and ultrasound 
showed heteroechoic fluid pocket 
subcutaneous but also possibly 
communicating with coffin joint. Incised 
area pocket, purulent material confirmed 
joint involvement 
+ + + + - - - - - + - - - - - 
S014 Foal Failure passive transfer (<200mg/dL) and 
neutrophilia, lame left front coffin. Started 
on systemic antibiotics and non-steroidal 
anti-inflammatory drugs which significantly 
improved lameness. Required 3L plasma to 

































































































































get immunoglobulin G over 800. Effusion 
right carpus, fluid returned no growth. 
Ultrasound consistent with moderate 
pneumonia and omphalophlebitis. 
Developed patent urachus. Systemic 
antibiotics changed from 
penicillin/gentamicin to ceftazidime. Joints 
treated with lavage and intraarticular 
aminoglycosides. Cell counts increased to 
180. Gentamicin added back in systemically. 
Cell count then plateaued around 80. More 
aggressive lavage and debridement of carpus 
did not improve cell count. Never lame on 
knee. Intermittent moderately lame on 
coffin. Synovial fluid had degenerative 
neutrophils at first but now nondegenerate. 
Ultrasound lungs and umbilicus and 
bloodwork relatively unremarkable. Now on 
chloramphenicol. Foal has every reason to 
have developed septic joints, but I have not 
been able to culture anything. No changes 
on radiographs. The cell count and 
appearance of cells (and history) support 


































































































































S015 Foal Acutely lame, right leg stifle effusion, 
started on systemic penicillin and 
gentamicin. Infection progressed to 
pneumonia, R. equi detected via tracheal 
wash sample 
- - - - - - - - - - - + - - - 
S016 Newborn Pneumonia and diarrhoea - on antibiotics - - + - - - - - - + - + - - - 
S017 N/A N/A + - + - - - - - - - - - - - - 
S018 N/A Potbelly, swollen LH distal limb, temp: 
38.7°C. RH distal limb swelling and temp: 
38.7°C. Treated with penicillin and 
gentamicin for 3 days and it resolved. Serum 
amyloid A:3000, white blood count: 
13.5X10g, Fibrogen:6, low total protein and 
albumin, chest and abdominal ultrasound 
found free fluid in both. Increased amount of 
comet tails. No thickened intestines 
+ + - - - - - - - - - + - - - 
S019 Yearling Swab from burst submandibular abscess. 
Potential Strangles. Mild temperature 
elevation (38.1°C vs normal 37.6°C) 
- - - - - - - - - - - - - - - 
S020 Yearling Submandibular abscess + - - - + - - - - - - - - - - 
S021 Yearling Temperature at 38.6°C, swelling under jaw 
with draining fluid. No nasal discharge. 

































































































































Bright and responsive 
S022 Yearling Abscessed lymph node under jaw - - - - - - - - - - - - - - - 
S023 Neonate Acute diarrhoea 17.2.17, temp was 40°C. 
Treated with calefour. 18.2.17 temp at 
39.2°C 




From the 23 animals screened (Table 3.3), 86.96% of samples returned 
positive for one or more PCR result, indicating successful amplification and 
confirmation of the presence of microbes. These positive samples were 
analysed to determine trends of infection types (Figure 3.6). Of the 23 
sterile sample types received and analysed by PCR, Gram positive 
pathogens (n=16) had the highest occurrence rate, with the potential to cause 
systemic or localised infection to horses of all age groups. Gram negative 
pathogens were the next most frequent (n=11) within the sample group. At 
the genus level it was Staphylococcus spp. that were observed to have the 
highest frequency (n=10). There were no observed PCR positives for either 
EHV-1 or EHV-4. 
 
 
Figure 3.6: Sterile pathogens PCR results. Occurrences represent the frequency of 
infection across samples received (n=23). 
 
To assess the frequency of polymicrobial infections, further analysis of 
Table 3.3 showed 43.48% of tested sterile samples returned PCR positive 
for both Gram positive and Gram negative infections. Excluding PCR 
results for Gram positive and Gram negative primers, the frequency PCR 
positives was assessed from information in Table 3.3 and presented in 
Figure 3.7, showing 10/23 (43.48%) sterile samples returned PCR positive 
for 2 or more genus or species specific and a maximum of 6 unique PCR 





Figure 3.7: Frequency of polymicrobial infections within sterile sample group 
where 1 equals PCR positive for 1 pathogen specific primer and 6 equals PCR 
positive for 6 pathogen specific primers. Data excludes PCR positives for Gram 
positive and Gram negative bacterial species.  
 
The largest age group represented within the sterile samples was newborns 
(n=9), where 88.89% of these returned a positive result for one of the primer 
sets used in the study (Table 3.4). Yearlings had the lowest percent positive 
results for a single age group at only 25%. 
 
Table 3.4: Frequency of PCR positive results by age in sterile grouped samples.  
Age 
Group 
Occurrence of positive 
PCR 




Newborn 8 9 88.89 
Neonate 1 1 100.00 
Weanling 0 0 0.00 
Foal 2 3 66.67 
Yearling 1 4 25.00 
2+ 0 0 0.00 




This data was presented showing the total distribution of infection with age 
groups (Figure 3.8). No strong observable trends correlating with age to 













3.5 Respiratory sample microbe identification 
Respiratory samples were obtained from veterinarians within the Greater Waikato Region and around Auckland, New Zealand which had 
information on the age group and clinical details that presented with suspected infection (Table 3.5). Each of these samples had the DNA 
extracted and were screened by PCR to determine which microbial species or genus returned positive. 
 
Table 3.5: Results from PCR test on respiratory samples, excluding PCR positive 16S which returned positive for all samples due to natural respiratory 
flora. Details of age, clinical details, and microbial species returning PCR positive (indicated by “+”) are shown.  
Sample 















































R001 N/A Exposed to horse with possible Strangles - - - - - - - 
R002 N/A Exposed to horse with possible Strangles - - - - + - - 
R003 N/A Exposed to horse with possible Strangles - - - - + - - 
R004 N/A Exposed to horse with possible Strangles - - - - - - - 
R005 N/A Exposed to horse with possible Strangles - - - - - - - 
R006 N/A Exposed to horse with possible Strangles - - - + - - - 
R007 N/A Exposed to horse with possible Strangles - - + - - - - 
R008 N/A Exposed to horse with possible Strangles - - - - - - - 






















































R010 N/A Exposed to horse with possible Strangles - - + - - - - 
R011 Foal Snotty nose - - + - - - - 
R012 2+ Exposed to horse with possible Strangles - - - - - - - 
R013 N/A N/A - - + - - - - 
R014 N/A Possible Strangles - - - - + - - 
R015 N/A Possible Strangles - - - - + - - 
R016 N/A Possible Strangles - - - - + - - 
R017 N/A Foal with purulent nasal discharge - - + + - - - 
R018 2+ Nasal discharge - + - - - - - 
R019 Yearling Nasal discharge - - - - - - - 
R020 Yearling Bilateral epistaxis, tachycardia, neurological (Mini breed)  - + + - - - - 
R021 N/A 
Normal foal, due to go home and want to check all is fine before it leaves since damn has 
nasal discharge 
- + + - - - - 
R022 2+ Nasal discharge and inflamed larynx - - - - - - - 
R023 2+ Nasal discharge - + - - - - - 
R024 N/A Swollen right side of face - came from sales - + - - - - - 
R025 2+ Nasal discharge - + - - - - - 
R026 N/A Suspected S. equi equi  - - - - - - - 






















































R028 N/A Suspected S. equi equi  - - - - - - - 
R029 2+ Swollen nares and mild nasal discharge - + + - - - - 
R030 2+ Lymphadenopathy - submandibular and nasal discharge - + - - - - - 
R031 Yearling 
Previous positive for S. equi equi - has now had 1x negative guttural pouch wash and 1x 
negative swab - this is the 3rd test 
- - - - - - - 
R032 2+ N/A - + - - - - - 
R033 2+ Nasal discharge - - + - - - - 
R034 N/A 
Purulent nasal discharge, slightly increased respiratory sounds, otherwise bright and 
responsive, recently weaned 
- - + - - - - 
R035 N/A 
Severe serious to mucoid bilateral nasal discharge. Swollen submandibular lymph nodes. 
Owner reports coughing. Rest of clinical within normal limits 
- - - - - - - 
R036 2+ 
Horse had bad respiratory infection in early January. Lingering bilateral nasal discharge. 
Endoscopic exam showed inflammation of pharynx and mucopus. Guttural pouches clean 
- - - - - - - 
R037 2+ Clear nasal discharge and cough, normal temperature and lung sounds - - - - - - - 
R038 2+ Seropurulent nasal discharge temperature and lung sounds normal - - - - - - - 
R039 N/A Coughing, bilateral purulent nasal discharge.  - + - - - + - 
R040 2+ Suspected S. equi equi - - - - - - - 
R041 N/A Pyrexia, purulent nasal discharge and cough - - + - + + - 
R042 N/A 
Pyrexia, purulent nasal discharge and cough. Tracheal wash - Pneumonia, nasal swab 
previously submitted 
- - + - + + - 






















































R044 N/A Swollen submandibular lymph nodes and pyrexia - - - - - + - 
R045 N/A Copious nasal discharge, no temperature + - - - - + + 
R046 2+ N /A - - + - - - - 
R047 N/A N/A - - + - - - - 
R048 Weanling Has nasal discharge and increased respiratory sounds - - - - - + - 
R049 Weanling Has nasal discharge and increased respiratory sounds. Has been coughing - - - - + - - 
R050 Weanling Coughing, mild nasal discharge and increased lung sounds - - + - - + - 
R051 Weanling Snotty nose, increased chest sounds, just been weaned, some are coughing - - + - - - - 
R052 Weanling Snotty nose, increased chest sounds, just been weaned, some are coughing - - + - - - - 
R053 Weanling Snotty nose, increased chest sounds, just been weaned, some are coughing - - + - - - - 
R054 Weanling Snotty nose, increased chest sounds, just been weaned, some are coughing - - + - - - - 
R055 Weanling Snotty nose, increased chest sounds, just been weaned, some are coughing - - + - + - - 
R056 Weanling Snotty nose, increased chest sounds, just been weaned, some are coughing - - + - - - - 




From the 57 animals screened (Table 3.5), 71.93% of samples returned 
positive for one or more PCR result, indicating successful amplification and 
confirmation of the presence of microbes. These positive samples were 
analysed to determine trends of infection types (Figure 3.9). Of the 57 
respiratory sample types received and analysed by PCR, S. zooepidemicus 
(n=22) had the highest occurrence rate, with the potential to cause systemic 
or localised infection to horses of all age groups. S. equisimilis (n=11) was 
the next most frequent, with EHV-4 (n=9) and R. equi (n=9) both having the 
third most frequent rate. 
 
 
Figure 3.9: PCR results from respiratory clinical samples. Occurrences represent 
the frequency of infection across samples received (n=57). 
  
To assess the frequency of polymicrobial infections, further analysis showed 
19.3% of the tested respiratory samples returned PCR positive for multiple 
pathogens (Table 3.5). Excluding PCR results for the 16S primers, the 
frequency of the PCR positives showed 11/57 (19.29%) respiratory samples 
returned PCR positive for 2 or more genus or species specific 
microorganisms and a maximum of 3 unique PCR positives within a single 





Figure 3.10: Frequency of polymicrobial infections within the respiratory sample 
group. Data excludes PCR positives for 16S primers. 
 
The largest age group represented within the respiratory samples was 
animals with uncategorised ages (n=28), where 71.43% of these returned a 
positive result for at least one of the primer sets used in the study (Table 
3.6). Yearlings had the lowest percent positive results for a single age group 
at only 33.33%. 
 




Total count of age group 
(n=57) 




Newborn 0 0 0.00 
Neonate 0 0 0.00 
Weanling 9 9 100.00 
Foal 1 1 100.00 
Yearling 3 1 33.33 
2+ 16 10 62.50 




This data was presented showing the total distribution of infection with age 
groups (Figure 3.11). No strong observable trends correlating with age to 













3.6 Gastrointestinal sample microbe identification 
Gastrointestinal samples were obtained from veterinarians within the Greater Waikato Region and around Auckland, New Zealand which had 
information on the age group and clinical details that presented (Table 3.7). Each of these samples had the DNA extracted and were screened 
by PCR to determine which microbial species of genus returned positive. 
 
Table 3.7: Results from PCR testing on gastrointestinal samples. Details of age, clinical details, and microbial species returning PCR positive (indicated by 
“+”) are shown. 





































































G001 N/A N/A - - + + + - - - -   
G002 N/A N/A - - - - - - + - +   
G003 N/A N/A - - - - - - + - +   
G004 Neonate Diarrhoea at 2 weeks old, one of a number affected between 2-10 
weeks old. - - - - - - - - -   
G005 2+ Colitis, suspected Salmonellosis. - - - - - - + - -   
G006 Yearling Yearlings with diarrhoea. Bright, eating, non febrile. - - - - - - - - -   
G007 Yearling Yearlings with diarrhoea. Bright, eating, non febrile. - - - - - - - - -   
G008 Foal Previous positive for C. difficile A + B. - - + + + - + - -   











































































G010 Foal Previous positive for C. difficile A. - - + + - - - - -   
G011 Yearling Previous positive for C. difficile A + B. - - + + + - - - -   
G012 N/A N/A - - - - - - - - -   
G013 N/A Previous positive for C. difficile B. - - + - + - - - -   
G014 N/A Negative for previous tests. - - - - - - - - -   
G015 N/A Negative for previous tests (Update 16/12/2015: R. equi). - - - - - - - - +   
G016 N/A Previous positive for C. perfringens PLC. - - - - - - + - -   
G017 N/A Negative for previous tests. - - - - - - - - -   
G018 N/A Negative for previous tests. - - - - - - - - -   
G019 2+ Recurrent smelly diarrhoea. - - - - - - - - -   
G020 N/A Positive for Salmonella. + - - - - - - - -   
G021 N/A Previous positive for R. equi. - - - - - - + - -   
G022 N/A Negative for previous tests. - - - - - - - - -   
G023 N/A Negative for previous tests. - - - - - - - - -   
G024 N/A Negative for previous tests. - - - - - - - - -   
G025 N/A Previous positive for R. equi. - - - - - - - - +   
G026 N/A Negative for previous test, suspected inhibitory. - - - - - - - - -   
G027 N/A Previous positive for Salmonella. + - - - - - - - -   











































































G029 N/A Previous positive for R. equi. Negative for VAP. - - - - - - - - +   
G030 N/A Previous positive for L. intracellularis. - + - - - - - - -   
G031 N/A N/A - - - - - - - - -   
G032 N/A N/A - - - - - - - - -   
G033 N/A N/A - - - - - - - - -   
G034 N/A N/A - - - - - - - - -   
G035 N/A N/A - - - - - - + - -   
G036 N/A N/A - - - - - + + - -   
G037 N/A N/A - - - - - - + - -   
G038 N/A N/A - - - - - - - - -   
G039 N/A 
N/A - - - - - - + - -   
G040 N/A N/A - - - - - - - - -   
G041 N/A N/A - - - - - - + - -   
G042 N/A Previous positive for R. equi and Salmonella. + - - - - - - - +   
G043 N/A Previous positive for Salmonella. + - - - - - - - -   
G044 N/A Previous positive for R. equi. - - - - - - + - +   
G045 N/A N/A - - - - - - - - -   
G046 N/A N/A - - - - - - - - - - 











































































G048 N/A Negative for previous tests. - - - - - - - - - - 
G049 N/A Rhodococcus. - - - - - - + - + - 
G050 N/A Previous positive for R. equi. - - - - - - - - - - 
G051 N/A N/A - - - - - - + - - - 
G052 N/A Previous positive for R. equi. - - - - - - + - + - 
G053 N/A N/A - - - - - - - - - - 
G054 N/A N/A - - - - - - - - - - 
G055 N/A N/A - - - - - - + - - - 
G056 N/A N/A - - - - - - - - - - 
G057 N/A Previous positive for Salmonella. + - - - - - - - - - 
G058 N/A Negative for previous tests. - - - - - - - - - - 
G059 N/A Previous positive for C. difficile B and Salmonella. + - + - + - - - - - 
G060 Yearling Chronic scours. - - - - - - - - - - 
G061 Neonate Diarrhea, losing protein.  - - - - - - - - - - 
G062 Neonate Acute diarrhoea 17.2.17, temp was 40°C. Treated with calefour. 
18.2.17 temp at 39.2°C. - - - - - - + - + + 
G063 N/A Enteritis. - - - - - - - - + - 
G064 N/A Diarrhoea, poor doer, fibrogen of 8. - - - - - - - - - - 
G065 Weanling Watery diarrhoea. Rhodococcus on farm. Suspected Rhodococcus or 











































































G066 Newborn 3 days old, diagnosed with pneumonia, has been on antibiotics for 
48 hrs. PCR and culture requested. Suspicious of L. intracellularis 
from ultrasound. Diarrhoea reported. - - - - - + + - - - 
 
95 
From the 66 animals screened, (Table 3.7) 54.5% of samples returned 
positive for one or more PCR result, indicating successful amplification and 
confirmation of the presence of microbes. These positive samples were 
analysed to determine trends of infection types (Figure 3.12). Of the 66 
respiratory sample types received and analysed by PCR, C. perfringens 
(n=18) had the highest occurrence rate, with the potential to cause systemic 
or localised infection to horses of all age groups. R. equi (n=13) was the 
second most frequent, with one sample returning a positive for R. equi VAP. 




Figure 3.12: PCR results from gastrointestinal clinical samples. Occurrences 
represent the frequency of infection across samples received (n=66). 
 
To assess the frequency of polymicrobial infections, further analysis showed 
24.24% of the tested gastrointestinal samples returned PCR positive for 
multiple pathogens (Table 3.7). The frequency of the PCR positives showed 
16/66 (24.24%) gastrointestinal samples returned PCR positive for 2 or 
more genus or species specific microorganisms and a maximum of 4 unique 





Figure 3.13: Frequency of polymicrobial infections within the gastrointestinal 
sample group (Excluding C. difficile; TcdA and TcdB counted independently). 
 
The largest age group represented within the gastrointestinal samples was 
animals with uncategorised ages (n=52), where 53.85% of these returned a 
positive result for one of the primer sets used in the study (Table 3.8). 
Yearlings had the lowest percent positive results for a single age group at 
only 25%. Newborns, neonates, and foals all had a positive frequency of 
100% (n=1). 
 
Table 3.8: Gastrointestinal age distribution of positive results. 
Age Group Number Occurrence of PCR Positive Positives frequency 
Newborns 1 1 100.00 
Neonates 3 1 33.33 
Weanlings 1 1 100.00 
Foals 3 3 100.00 
Yearlings 4 1 25.00 
2+ 2 1 50.00 
N/A 52 28 53.85 
 
This data was presented showing the total distribution of infection with age 
groups (Figure 3.14). No strong observable trends correlating with age to 













3.7 Sequencing results  
To confirm the accuracy of each PCR primer set and validate the results, 
amplified PCR products from clinical samples were sent for sequencing. 
Some sequencing returned indeterminable results (Table 3.9), whereas other 
sequencing was able to be imported into NCBI BLAST to confirm 
amplification or the correct product and in some cases allowed microbe 
detection at a species level. 
 
Table 3.9: Table of PCR sequencing results that were of poor quality and unable to 
be analysed using BLAST.  
Sample ID Genus primers Quality Length (nucleotides) 
G063 VAP 1% 193 
R003 EHV-4 (TK) 3.30% 275 
S003 
Staphylococcus spp. 0.00% 5 
Gram positive 0.00% 307 
S004 
Gram negative 0.50% 409 
Panfungal 0.20% 468 
S005 
Coliforms 0% 63 
Gram negative 0.60% 328 
S006 Staphylococcus aureus 0% 5 
S008 
Gram negative 1.40% 418 
Gram positive 9.50% 317 
Panfungal 0.30% 470 
S009 Gram positive 0.70% 282 
S011 Gram positive 0.00% 199 
 
Out of the 14 low quality sequencing results received, 7/14 (50%) of 
samples were for 16S bacterial primers (Table 3.9). Despite this, some of 
these samples were successfully sequenced (G063, R003, S004, S006, S008, 
S011) when different microbial primers were used (Table 3.10). BLAST 
analysis of these sequences showed species identification similar to what 
was expected from the amplicon (Table 3.10). However, irregularities did 
occur during the BLAST analysis of S015, which presented with high 
quality sequencing, but the BLAST analysis returned DNA for a tescalcin 
gene from a Przewalski’s horse, and not virulence associated plasmid genes 







Table 3.10: Table of PCR sequencing results following successful NCBI BLAST analysis. 
Sample 























Clostridium perfringens, enterotoxin 








R. equi, cholesterol oxidase (choE) 




C. perfringens, phospholipase C 
precursor (plc) gene,  479 479 100 2E-131 99 HM625066.1 
TraA 680 R. equi virulence plasmid 1254 1254 100 0E+00 100 AF116907.2 
VAP 181 R. equi virulence plasmid 335 335 100 3E-88 100 AF116907.2 




Equid herpesvirus 4 glycoprotein 




Equine herpesvirus type 1 




Equine herpesvirus type 1 
glycoprotein 14 (gp14) gene 590 590 100 1E-164 100 M34861.1 
R039 CHO 199 R. equi 350 350 94 1E-92 100 FN563149.1 
R041 Streptococcus spp. 196 Streptococcus acidominimus  351 351 100 3E-91 99 AY266992.1 
R042 
Streptococcus spp. 195 Streptococcus pneumoniae 294 294 100 5E-76 94 AP018043.1 










































Staphylococcus epidermidis 534 534 95 5E-148 97 CP022247.1 
Streptococcus spp. 195 Streptococcus pneumoniae 342 342 99 2E-90 98 AP018043.1 
S007 




Staphylococcus epidermidis 617 617 99 5E-173 97 CP022247.1 
Streptococcus spp. 191 Streptococcus pseudopneumoniae 348 348 100 4E-92 99 GU326209.1 
S008 
Coliforms 228 Escherichia coli 422 422 100 3E-114 100 CP023388.1 




Staphylococcus epidermidis 545 545 100 2E-151 99 CP022247.1 







































Uncultured Staphylococcus sp. 
















Staphylococcus equorum 643 643 100 0E+00 100 CP013980.1 
S023 
Bacillus spp. 208 Bacillus cereus 351 351 94 3E-93 99 KY675383.1 
GmPos 333 Bacillus cereus  604 8403 100 4E-169 99 CP017060.1 









Sequencing results analysed in Geneious showed varying levels of efficiency (Figure 3.15 and Figure 3.16). Electropherograms show 
the quality of sequencing returned and demonstrates the accuracy of the PCR and the products amplified. A full list of electropherogram 
sequencing quality for associated primers can be found in Appendix 3.  
 
 








Figure 3.16: Example of high quality sequencing and alignment for the products obtained for the Gram negative 16S primers from sample S013.  
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3.9 Confirmation of primer efficiency 
Primers were initially tested to ensure they were able to generate amplicons 
of the correct size. Amplified products were compared to a 100bp molecular 
weight ladder to ensure product size matched the expected product size 
described by the literature primers were retrieved from.  
 
3.10 PCR products amplified from sterile samples 
DNA from sterile samples was tested with primers for Gram positive 16S, 
Gram negative 16S, Staphylococcus genus, S. Aureus, Streptococcus genus, 
E. coli, Coliforms, Enterococcus genus, Bacillus genus, Pseudomonas genus, 
R. equi (CHO), Panfungal genus, EHV-1 and EHV-4 (Figure 3.17). 
Amplicons of the correct size were obtained for each set of primers. 






Figure 3.17: Gel electrophoresis image of amplified bacterial, fungal, and viral 
products using primers with DNA extracted from various sterile clinical samples. 
Lane 1: Genscript 100bp ladder; 2: Gram positive 16S; 3: Gram negative 16S; 4: 
Staphylococcus genus; 5: S. Aureus; 6: Streptococcus genus; 7: E. coli; 8: 
Coliforms; 9: Enterococcus genus; 10: Bacillus genus; 11: Pseudomonas genus; 12: 
Genscript 100bp ladder; 13: Genscript 100bp ladder; 14; R. equi (CHO); 15: 
Panfungal genus; 16: EHV-1; 17: EHV-4; 18: Genscript 100bp ladder. Primer 
dimers (boxed) can be observed in some lanes. 
 
 
3.11 PCR products amplified from respiratory samples 
DNA from respiratory samples was tested with primers for S. equi equi, 
S. equi (EqbE), Gram positive 16S, S. equisimilis (equisim) and 
S. zooepidemicus (sodA) (Figure 3.18 and Figure 3.19). Amplicons of the 
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correct size were obtained for each set of primers. However, primer dimers 
could be observed in some of the amplified products.  
 
 
Figure 3.18: Gel electrophoresis 
image of amplified bacterial products 
with DNA extracted from a 
respiratory clinical sample. Lane 1: 
Solis Biodyne 100bp ladder; 2: S. equi 
equi (seel) at 520bp, 16S positive 
control at 410bp, S. equisimilis 
(equisim) at 279bp, S. zooepidemicus 
(sodA) at 235bp. 
 
Figure 3.19: Gel electrophoresis 
image of amplified bacterial products 
with DNA extracted from a 
respiratory clinical sample. Lane 1: 
Genscript 100bp ladder; 2: S. equi 
(EqbE) at 324bp, sorD at 220bp.  
 
 
3.12 PCR products amplified from gastrointestinal samples 
DNA from gastrointestinal samples was tested with primers for 16S rRNA, 
Salmonella, L. intracellularis, TcdA, TcdB, C. perfringens, C. sordellii, 
R. equi and associated virulence markers (Figure 3.20 - Figure 3.26). 
Amplicons of the correct size were obtained for each set of primers. Primer 
dimers could be observed in some of the amplified products. PCR positive 
image of L. intracellularis from sample G030 could not be obtained for 





Figure 3.20: Gel electrophoresis image 
of amplified bacterial 16S PCR products 
with DNA extracted from a 
gastrointestinal sample. Lane 1: 
Genscript 100bp ladder; 2: 16S.  
 
Figure 3.21: Gel electrophoresis image 
of amplified bacterial PCR products 
with DNA extracted from a 
gastrointestinal sample. Lane 1: 
Genscript 100bp ladder; 2: Salmonella. 
 
Figure 3.22: Gel electrophoresis image 
of amplified bacterial PCR products 
with DNA extracted from a 
gastrointestinal sample. Lane 1: TcdA 
and TcdB; 2: R. equi CHO positive; 3: 
SolisBiodyne 100bp ladder; Primer 
dimers (boxed) can be observed in some 
lanes.  
 
Figure 3.23: Gel electrophoresis image 
of amplified bacterial PCR products 
with DNA extracted from a 
gastrointestinal sample. Lane 1: 
Genscript 100bp ladder; 2: 
C. perfringens PLC positive 3: C. 
sordellii negative 4: C. perfringens netF 
negative; 5; C. perfringens PLC 
positive; 6: C. sordellii positive. Primer 






Figure 3.24: Gel electrophoresis image of amplified bacterial PCR products with 
DNA extracted from a gastrointestinal sample. Lane 1: Negative control. Lane 2: 
CHO positive. Lane 3: CHO Positive. Lane 4: CHO positive. Lane 4: Genscript 
100bp ladder. Primer dimers (boxed) can be observed in some lanes. 
 
 
Figure 3.25: Gel electrophoresis image of 
amplified bacterial 16S PCR products with 
DNA extracted from a gastrointestinal 
sample. Lane 1: Genscript 100bp ladder; 2. 
VAP positive; 3. VAP positive. 
 
 
Figure 3.26: Gel electrophoresis image of 
amplified bacterial 16S PCR products with 
DNA extracted from a gastrointestinal 
sample. Lane 1: TraA negative; 2: TraA 
positive; 3: TraA negative; 4: TraA; 5: 
Genscript 100bp ladder. Primer dimers 





3.13 Restriction digests 
Due to the clinical significance of Equine herpesvirus, restriction digests 
were used to confirm the presence of EHV-1 and EHV-4 to mitigate false 
positives occurring from mispriming. The changes seen following a 
restriction digest of the PCR product with the relevant restriction enzyme 
allowed the confidence to conclude the presence of EHV-1 and EHV-4 
within clinical samples. 
 
 
Figure 3.27: Gel electrophoresis image of a PCR restriction digest for the 
confirmation of Equine herpesvirus. Lane 1: Genscript 100bp ladder; 2: EHV-1 
PCR amplicon; 3: EHV-1 amplicon digested with HincII; 4: EHV-4 PCR amplicon; 






4 Chapter Four 
DISCUSSION 
 
Culture based diagnosis is a limited diagnostic technique, as only organisms 
suited to a particular media will grow and has the potential to produce a 
false negative result. To achieve accurate culturing many selective or 
enriched media must be used, particularly when detecting microbes in non-
sterile samples, such as faeces. The use of additional selective media 
significantly increases the costs associated with culturing, and the trial-and-
error approach of culturing with many different media increases the time for 
diagnosis. In addition to the shortfall of media specificity, culturing can also 
be inhibited following the application of antimicrobials as therapeutic 
treatments leave the pathogenic organism undetected. The accurate 
identification of these organisms is invaluable, allowing easier detection 
within groups of animals that may be vulnerable to infection and for the 
administration of the correct therapeutic approach that will mitigate the 
spread of infection. 
 
Due to the relative low sensitivity, expense, and extensive diagnostic time 
required, there is a pressing need for alternative equine diagnostic methods. 
Compared to traditional methods, PCR is rapid, bypasses the need for 
selective media, lowers expense, and provides same day results. It still 
requires specialist skills, as DNA must be extracted from the sample and 
added to specific reactions. Also, critical for any PCR is the correct primer 
selection, which can be overcome over time, through the collection of 
further information on common infections present. The additional use of 
known universal primers are important, as they can be used as indicators of 
successful amplification and determine the presence of infection within 
normally sterile samples. However, it is important to note, that there is the 
potential for these primers to react with any bacterial DNA that is present 
within TAQ polymerase being used and they may not be reliable with the 
occurrence of polymicrobial infections as often these cannot be accurately 




The overall aim of this project was to compare the efficacy of molecular and 
traditional diagnostic techniques for the identification of microbes 
responsible for infection in equines. 
 
 
4.1 Traditional culture method efficiency 
Out of 13 cultures, 6 were able to be identified to a genus level using simple 
Columbia broth and blood agar approaches. This method took on average 48 
hours, where microbes were initially grown in broth, streaked onto agar, and 
allowed to grow into single colonies. Identification then used morphological 
characteristics and Gram staining. 
 
Not all sterile samples received from veternarians (n=23) were able to be 
cultured in media, due to the sample type. For example, swab based samples 
could be used for either PCR or culture, not both. Due to this the results 
section on culture material ended up being relatively low. This does 
however highlight another limiting factor, the volumes required for 
diagnostics to be carried out. Due to PCR amplifying DNA exponentially 
with each cycle, a minimum of one DNA template strand at the first round 
of PCR has the potential to be amplified to over 34 billion amplicons 
following a standard 35 cycle program. Our DNA extraction technique used 
0.2 ml of equine blood, compared to a mean of ~30ml of blood, that is used 
to detect bacterial infection using culture in medical pathology (Bouza et al., 
2007). This comparison clearly shows a distinct advantage molecular 
diagnostic techniques have over traditional methods. 
 
Identifying microbial organisms in a culture was also more challenging 
overall when compared to PCR. Determining the causative pathogen using 
traditional culturing is a multifactorial process, requiring the use of multiple 
growth media, plates, various stains, and a knowledge of the potential 
pathogens involved. Traditional methods have proven useful for a rough 
guidance to treatment, however, the time require to obtain these results 
needs to be taken into consideration. Gram stains, which determine if an 
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organism is Gram positive or Gram negative take mere minutes, however, 
the blood or sample of infection takes a minimum of 12-24 hours to begin 
growing to a stage where identification using the morphological 
characteristics of a pathogen are possible. It must also be noted that bacterial 
culturing will only identify the presence of bacteria. Additional culturing 
methods must be undertaken to identify any fungal or viral microbes that 
may also be present.  
 
 
4.2 Shortfalls of traditional culture methods 
The known shortfalls of bacteriological culturing methods that have driven 
this project were recognised during our attempts at culturing. Growing 
bacteria in a basic culture broth took a minimum of 12 hours, and another 12 
hours to grow identifiable colonies on blood agar. These basic culturing 
methods were insufficient for detecting fungi and viruses, and were only 
suitable for identifying select bacterial species. In addition to this low 
sensitivity we were unable to detect polymicrobial infections using blood 
agar and Columbia broth alone, indicating that if this was used as the 
primary diagnostic technique, many results received would have been 
incomplete or provided false negatives. Culture based diagnosis requires a 
high level of expertise, firstly to determine what culture medias to use, and 
secondly to interpret the result. This leaves this technique prone to human 
error and subjectivity. Although once considered the gold standard, for the 
detection of pathogenic microbes in horses bacteriological culturing is not a 
sufficient diagnostic tool, due to difficulty, and high rates of potential false 
negatives (Furr, 2003).  
 
 
4.3 Efficacy of DNA extraction techniques 
Nanodrop spectrophotometer results showed varying levels of DNA 
template purity following extraction from clinical samples. DNA 
quantification and qualification results from Nanodrop spectroscopy showed 
the SDS lysis method consistently produced higher quality and quantity 
DNA from clinical blood samples compared to the GITC extraction 
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methods. However, optimisation of these extraction techniques still requires 
further investigation, as a more rapid extraction technique could further 
speed the diagnostic time. In addition to this, alternative DNA extraction 
techniques such as PEG/KOH or kit based methods have the potential to 
produce high quality DNA from multiple clinical samples using a single 
procedure, further simplifying mass sample processing, and potentially 
decreasing the time required from sample reception to analysis of PCR.  
 
 
4.4 Development of molecular approach 
By developing PCR protocols sufficient to amplify multiple products related 
to clinical pathogens we were able to provide diagnostic information for the 
guidance of treatment. TD-PCR which was used due to variable 
manufacturer recommended melt temperatures from different primers, 
provided a sufficient method of tandem amplification of multiple PCR 
products, however, the efficiency of amplification for some primers was 
lowered due to the generalized PCR protocols. This could be mitigated by 
alternative primer design, however, artefacts like non-specific amplification 
and low resolution bands can still be used for diagnostic purposes. 
 
The use of virulence associated primers proved useful in discriminating 
environmental and pathogenic species, and this could be applied further in 
primer development. By designing pathogen specific primers for other 
species, such as potential commensal gut species PCR diagnosis may have 
increased efficiency in discriminating commensal and pathogenic species. 
 
Multiplex primers were used in some instances so simplify PCR protocols, 
increasing the throughput, and lowering risk of human error. Although 
convenient, occasionally DNA extraction artefacts such as organic inhibitors 
from clinical samples could interfere with the efficacy of multiplex PCR and 
cause false positives or false negatives, therefore uniplex reactions were 
used for the majority of testing to ensure this did not occur. With further 
replication and optimisation the introduction of multiplex primers for most 
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species specific primers would prove useful for increasing throughput and 
decreasing rates of potential human error.  
 
 
4.5 PCR efficiency  
The PCR protocols used in this project all use TD-PCR to decrease non-
specific binding, which allowed for the use of multiple sets of pathogen 
primers within one thermal cycler run. Using known isolated specimens as 
positive controls, each PCR produced high quality bands. However, the use 
of DNA template derived from clinical samples resulted in the quality of 
PCR products and specificity to be lowered. Despite this, these PCR 
products were still of sufficient quality for analysis and diagnostics (Figure 
3.17 - Figure 3.26).   
 
One of the biggest advantages of PCR in diagnosis is the ability to exploit 
genes related specifically to the virulence of a pathogen. By using CPE, 
netF, and VAP it was possible for us to differentiate between commensal 
and pathogenic forms of a microbe using the same technology in tandem 
with the initial diagnostic process. DNA sequencing proved the accuracy of 
these additional primer sets, and were sufficient to differentiate between 
virulent and non-virulent strains, necessary to guide treatment. 
Unfortunately, netF did not show any positive results, and therefore primers 
efficiency cannot be validated, however, netF has yet to be reported in New 
Zealand. The acquisition of a purified netF sample would allow for the 
validation of these primer sets, allowing for the use of this to monitor and 
identify when different pathogens enter New Zealand as performed in 
Gohari et al. (2015) for the testing of cows and foals.  
 
The appearance of non-specific bands forming with clinical samples created 
the need for a secondary molecular procedure to confirm the accuracy of 
amplification. In one case, two restriction enzymes were used to run 
conclusive restriction digest experiments to confirm the amplified bands 
were the expected product. This method was similar to diagnostic 
methodology used in detecting human adenovirus (Allard et al., 2001). The 
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combination of PCR and restriction enzyme (PCR-RE) allowed rapid and 
reliable identification of subgroups of adenovirus. This technique can be 
applied to pathogen detection confirmation, offering a reliable result faster 
than DNA sequencing. Although these additional digests extended the 
diagnostic time by a minimum of 4 hours they allowed a reliable 
confirmation that was further clarified using DNA sequencing (EHV-1 & 
EHV-4 electropherograms, see Appendix 3). 
 
DNA sequencing was used to confirm both the accuracy of primer 
amplification and identify the pathogen at a species level by using BLAST 
to analyse sequence data. The quality of DNA sequencing was highly 
variable, and can be attributed to multiple factors. On occasion, non-specific 
binding and primer dimers during PCR amplification had to potential to 
reduce the quality or length of DNA sequencing (Rychlik, 1995). Also, 
DNA sequencing electropherograms frequently showed multiple peaks, 
indicating multiple, non-identical DNA sequences were being sequenced 
and read simultaneously by the capillary mechanism, a phenomenon 
recognised from the DNA sequencing of multiple pathogens (Hartmeyer & 
Justesen, 2010). This irregularity was seen strongly in sequencing results 
from 16S rRNA primers and can be attributed to the presence of multiple 
microbes causing multiple amplicons from different species. For non-16S 
rRNA genes, better DNA sequencing results could be obtained by using a 
different PCR product purification method, such as a gel extraction, cloning 
of the PCR product, or through more specific primer design.  
 
Overall, the confidence gained from sequencing the PCR products meant it 
was possible to provide a provisional diagnostic result within 6-24 hours 
and confirm with sequencing within 5 days. Returning provisional results 
back within a short time frame, meant that veterinarians were able to make 
modifications to any ongoing treatment. Restriction digests of PCR products 
were extremely useful as they confirmed the result without sequencing and 





4.6 Use of PCR to diagnose horse infections 
Rapid diagnostic techniques have an important place in veterinary medicine, 
helping to mitigate otherwise avoidable spread of diseases and infections. 
Of the 146 total samples received for testing, 66.4% returned a PCR positive 
for one or more of the infection indicative primers. In contrast, culturing 
methods only succeeded in identifying 46% of samples cultured to a species 
level. All positive PCRs were sequenced to prove the correct amplification 
of products and to help in the diagnosis of the causative microbe. 
 
In most cases, the sequencing results confirmed the reliability of PCR 
primers for equine diagnostics with all but one high quality sequencing data 
returning a BLAST result suitable to the gene sequenced. This provided 
good evidence that the primers used within the study were appropriate for 
the amplification of these pathogenic genes, and therefore for diagnostics. 
Species level data obtained through BLAST analysis reflected previous 
information on suspected pathogens found in literature (McKenzie III & 
Furr, 2001; Toombs-Ruane et al., 2016), with S. pneumoniae¸ S. 
epidermidis, and S. equorum occurring within multiple clinical samples.  
 
It is important to note that R. equi primers CHO consistently produced low 
quality sequencing with lowered lengths and poor alignment, resulting in 
either the forward or reverse sequence being available for sequence analysis. 
Another irregularity noticed during BLAST analysis was within the forward 
sequence for vapA from S015, which at a trimmed length of 136 nucleotides 
returned a strong identity score to a tescalcin gene from Equus przewalskii 
and was not related to the R. equi virulence associated proteins. Through 
further investigation it was discovered that the 136bp PCR product Figure 
A3.18 shared a 94.9% similarity to Equus przewalskii tescalcin gene (NCBI 
accession: XM_008515476.1). This amplified area Figure A3.19 then 
shared a 56.6% similarity when mapped to the R. equi virulence plasmid 
(NCBI accession: AF116907.2). Figure A3.20 shows the areas of the Equus 
przewalskii tescalcin gene in which the vapA primers bound, producing 
amplicons falsely identified as R. equi. This irregularity was noted and use 
of vapA primers was discontinued and replaced with VAP, which produced 




Generally, 16S rRNA Gram positive and Gram negative primers returned 
low quality results, however their use within diagnostics should not be 
discontinued, with generalised primers incorporated for validating 
procedures. Generalised 16S rRNA primers provide a good positive control 
in sample testing, ensuring the PCR works, and identifying the presence of 
abnormal pathogens within normally sterile sample types. Additionally, in 
non-sterile samples, the use of 16S rRNA primers can assist in the detection 
of inhibitory compounds that may cause false negatives in testing which 
otherwise would have been previously diagnosed as an absence of infection.   
 
Using a panel of primers to a variety of microbes the following samples 
were screened: 
 
i)  Sterile samples 
86.96% of all sterile samples returned PCR positive and 73.9% of results 
were identified at a genus level or higher, signifying the sensitivity of 
molecular technique. In comparison, 84.62% of culturing results produced a 
result (defined as growing within growth media), but only 46.15% returned 
a result that could be identified at a genus level. Additionally, methods 
needed to culture and return a result were more variable than methods used 
for PCR, which were more consistent following DNA extraction.  
 
Within sterile samples, high levels of Gram positive infections and 
significantly higher occurrences of Staphylococcus spp. were seen which 
follow the trends expected and reported in the literature (Toombs-Ruane et 
al., 2016). These trends were also seen within the age divisions, with nearly 
50% of sterile samples coming from newborn animals, which is the age 
bracket of vulnerability that is associated with increased risk of systemic 
infection. It appears that prevalent systemic pathogens follow trends 
expected from the limited literature on NZ sepsis, however this could also 
be due to our primer choices being influenced around pathogenic species 




The specificity and efficacy of detection using PCR in sterile samples could 
be significantly increased, as these sample groups are not affect by the 
presence of environmental pathogens that may cause false positives. This 
could be achieved by designing additional primers at a genus or species 
level for species known or suspected to cause infections within sterile sites. 
Determining these likely species can be achieved by retrospectively 
analysing culture results received from these or similar sites within the same 
geographical location, or through literature searching. With the introduction 
of extra primers into this PCR panel, sensitivity, and the ability to exactly 
identify organisms causing infection would increase, however, the time 
required to set up more reactions would also increase. This could be 
mitigated by the introduction of multiplex PCR which would use these 
primers, within one tube, lowering the time needed to set reactions up. This 
also has the potential to lower error rates associated with pipetting into 
many individual tubes and they can be set up and optimised through the use 
of multiple concentration and temperature gradients before use with clinical 
samples.  
 
ii)  Respiratory samples 
By using established PCR protocols, DNA extraction techniques, and PCR 
primers derived from a previous study (Patty, 2012; Patty & Cursons, 2014), 
respiratory samples produced high quality results within a short time frame. 
As respiratory samples were mostly received as dry swabs or swabs in 
saline solution, the DNA extraction process was faster, compared to 
gastrointestinal or sterile samples as there was no need for extensive 
treatment to remove potentially inhibitory compounds. It is important to 
note that a limited number of swabs were delivered in an agar media which 
carried over contamination of an agar substance into the extracted DNA, 
which proved inhibitory in PCR, giving false negative samples. These false 
negatives were noticed due to the use of a universal 16S primer set with the 
respiratory samples, used to ensure correct amplification in all samples.  
 
Results for respiratory disease were limited, due to the non-sterile nature of 
the nasal tract, which negated the use of broad primer sets that would 
amplify commensal bacteria in the upper respiratory tract. The sensitivity of 
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this primer assay could be improved by the addition of more species specific 
primers against organisms, such as S. pneumoniae, Pasturella spp., and 
Equine rhinovirus (Dunowska et al., 2002b; Wood et al., 1993). This same 
methodology could also be implemented for the detection of Equine 
influenza control if this virus became present within NZ as accurate PCR 
primers have already been validated for virus identification (Foord et al., 
2009). 
 
iii)  Gastrointestinal samples 
The molecular analysis of gastrointestinal infection showed high detection 
rates, however, the range of primers available limit the number of species 
that were able to be detected. Also, due to the absence of clinical 
information, it was not possible to make any conclusions about age trends in 
the Waikato region and infection.  
 
Improvement of gastrointestinal molecular diagnosis requires the 
introduction of more specific primer sets and of methodology that can assess 
the level of the pathogen and its amplification. Similar to the respiratory 
tract, over colonisation of the gastrointestinal tract with commensal bacteria 
can cause gastrointestinal infection in animals, and these infections are 
rarely detected due to the regular presence of these microbes within the gut. 
To achieve this level of detection it would be necessary to use a more 
quantitative molecular method to detect the abnormality of pathogens within 
a faecal sample. qPCR or digital PCR would allow this, by obtaining the 
actual levels of certain pathogenic species, such as E. coli. Early 
amplification compared to the control would be indicative of an 
overabundance of that microbe within the gastrointestinal tract. Such 
technology has already been used in the detection of Salmonella spp. which 
are not part of the normal gastrointestinal flora of horses, but may be present 
in some animals carrying infection (Pusterla et al., 2010). Detecting non-
commensal gastrointestinal pathogens that may also be found in a healthy 
gut could also be achieved using primers associated with virulence, such as 
the VAP primer used in distinguishing facultative and pathogenic R. equi 
species. While incorporating additional primers it would be of value to 
identify primers suitable for the detection of the RNA virus, equine 
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rotavirus as it’s prevalence in NZ equines warrants rapid detection and 
should not be overlooked (Horner, 1989). Primers to accomplish this 
detection have been used for the identification of Group A rotaviruses and 
provide a valuable starting point (Collins et al., 2008). 
 
These results from this investigation show varying efficiencies of PCR 
detection, however, with further development, and the widening of pathogen 
search primers this method could provide an accurate and high throughput 
method of pathogen identification in NZ veterinary settings.  
 
 
4.7 Shortfalls of molecular approach 
There are a number of things that can affect the efficiency of PCR diagnosis, 
including determining appropriate and unique target sequences, primer 
design, type of PCR technology being used, DNA extraction methods and 
PCR product detection that are suitable for a mass panel of detectable 
species (Yamamoto, 2002). However, these are often able to be mitigated 
through the optimization of PCR protocols. Current PCR panels do not 
include all potential pathogens that could be present causing infection, 
meaning selected pathogenic species are often overlooked (Lehmann et al., 
2008). Inhibitory compounds present in the PCR template such as enzymes 
or reagents can affect the amplification of PCR making it difficult with non-
pure clinical samples, such as those from tissue (Stefańska et al., 2016). In 
addition, some pathogenic species may be more difficult to be lysed or 
extracted from the sample meaning they can be missed (Stefańska et al., 
2016). The availability of multiple DNA extraction techniques, depending 
on sample type, often means the DNA template used with any kind of 
molecular technique can be vastly different and can affect the accuracy of 
downstream applications. An absence of standardisation of these extraction 
methods can confound results, particularly as poorly purified DNA can be 
inhibitory to PCR (Schrader et al., 2012).  
 
When testing for a panel of infectious organisms PCR conditions need to be 
similar in order to run multiple samples in tandem. Unfortunately different 
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primers for different genes can require vastly different PCR cycling 
conditions. To mitigate this issue an example of specific PCR technology is 
the use of TD-PCR. PCR is also subject to the risk of carry-over 
contamination from reagents, workers, tools, and other samples which have 
the potential to contaminate subsequent samples leading to false positives in 
DNA amplification diagnosis, therefore, extreme care must be taken to 
avoid this in order to maintain the accuracy of PCR diagnosis.  
 
 
4.8 Molecular versus traditional diagnostic approaches 
From our investigation we have seen that molecular diagnostic techniques 
are faster, and more sensitive than traditional culturing methods, and these 
advantages make PCR diagnostics a valuable addition to veterinary care. 
PCR took between 6-12 hours to complete following sample reception, 
which included a maximum of 2.5 hours to extract DNA, 3 hours for PCR, 
and 30 minutes for agarose gel electrophoresis and visualisation. Culturing 
methods often took 48 hours for analysis following sample reception, which 
included 12-24 hours for the blood sample to grow in culture broth, another 
12-24 hours for single colony streaks to form on the agar, and 15 minutes to 
visualise a single colony with Gram staining.  
 
In terms of the frequency of positive results, PCR using sterile samples 
identified the most pathogens from each sample, and this is linked to the 
fact that sterile samples will not normally have any commensal microbial 
species present, allowing us to search for any pathogens. Comparatively, the 
variety of identified pathogens in respiratory and gastrointestinal samples 
was lower due to the restrictions on primer choice as a result of the presence 
of commensal microbial species in these areas.  
 
The results received using traditional culturing methods were limited by the 
use of a single growth medium. Although there was evidence of bacterial 
growth in 85% of cultured samples, due to the presence of turbid media, we 
were unable to identify all microbes to a genera level in all samples. In 
addition, using culture we were unable to identify any viral or fungal species, 
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whereas PCR identified both viral and fungal species using identical 
methods that were used for the identification of bacteria.  
 
A big advantage that bacterial, viral, and fungal culturing does hold over 
both PCR based methods is the ability to differentiate between live and dead 
microbes. Due to the high specificity of molecular techniques it is possible 
for them to amplify and return positive results to microbes which may have 
been present but not necessarily responsible for infection. This overly 
sensitive feature may actually cause veterinarians to overlook possible 
causes of infection and therefore misdiagnose and apply inappropriate 
treatment. Due to the nature of cultures, only live microbes will be 
transferred from the animal and grow within the correct growth media  
(Kralik & Ricchi, 2017). Another advantage of culturing is the ability to 
perform antibiotic sensitivities on the colonies isolated, which proves useful 
in prescribing therapeutic treatment.  
 
Despite this, molecular methods are clearly useful in identifying bacteria 
and other pathogenic microbes alongside or instead of typical culturing 
methods. PCR exhibits higher sensitivity and specificity, and can help 
reduce subjectivity when interpreting the morphological aspects involved 
with traditional culturing methods (Settanni & Corsetti, 2007). 
 
 
4.9 Future of PCR in diagnostics 
Worldwide PCR is being used as a detection technique for infection in 
human and veterinary settings. Predominantly in equine husbandry PCR is 
currently being used to identify viruses, such as Equine herpesvirus, or as a 
rapid identification of particularly virulent infections such as Strangles 
(McBrearty et al., 2013; Patty & Cursons, 2014). To our knowledge at this 
point PCR is not being used as a sole diagnostic testing method in NZ 
equines. Based on results across the three sample groups, PCR detected 
microbes matched similar trends that had been previously identified in NZ 





However, before introducing an entirely PCR based diagnostic scheme into 
commercial veterinary laboratories it would be wise to amend some of the 
protocols used in this investigation to increase the efficiency, accuracy, and 
usability of the PCR assays. Extending the primer range of each group 
would increase the diagnostic sensitivity, particularly including primers for 
pathogens that pose the most significant risk to the equine industry, such as 
equine influenza. To aid in the ease of replication, and to reduce the risk of 
pipetting error causing false negatives it would be advisable to develop 
primers that could be adapted for multiplex PCR, combining related genes 
using primers to R. equi along with a primer set that identifies VAP that 
allow the identification of the presence and virulence of a selected pathogen. 
It would also be important to develop accurate primers for detecting RNA 
viruses, such as those associated with equine rotavirus as it may be possible 
to identify these using identical methods.  
 
 
4.10 Alternative molecular approaches in diagnostics 
Due to the time sensitivity associated with equine diagnostics, particularly 
in the case of sepsis there is the opportunity to exploit technology that speed 
up the diagnosis outcome. For example, column based extraction kits, and 
the use of platforms such as quantitative PCR (qPCR) to identify pathogens 
within a sample would help to lessen the time it takes to identify using the 
current chloroform based extraction and PCR, used in this investigation. 
Kits, such as Promega Wizard® SV96 kit or Bilatest bead DNA 2 kit, tested 
for efficiency and throughput using mammalian blood cells are capable of 
producing high quality DNA with ease, and in a short timeframe (<30 
minutes) required for diagnostic medicine (Smith et al., 2003). Developing a 
multiplex qPCR procedure following a rapid kit DNA extraction would 
allow the identification of pathogens rapidly and more effectively, such as 
those seen in human LightCyclerSeptiFast which has a sensitivity at 95% 




Despite the small number of positive results obtained from this investigation 
the trends did follow those reflected within the literature, allowing us to 
confirm the current trends surrounding the causes of infection in New 
Zealand equines. These epidemiological trends can be used to drive the 
development of other highly sensitive and effective molecular approaches, 
such as loop-mediated isothermal amplification (LAMP) or ELISA (Nemoto 
et al., 2010). Using the findings from this study and previous ones, 
complimentary antibodies could be developed to the most prominent 
infection causing microbes and an ELISA assay developed, specific for each 
infection type. This would allow for not only rapid assay based testing for 
common equine infections, it would also allow for these detection methods 
to be undertaken with ease on the farm, avoiding the time wasted with 
sample postage and delivery that often slows down diagnostic times. 
Although no current literature describes the use of ELISA in on farm 
pathogen detection in horses, this methodology has been used in the 
measurement and detection of other serological samples and other animals 
such as measuring progesterone in dairy cattle milk, demonstrating the 
viability of testing without a wet lab (Rajamahendran et al., 1990).  
 
Lastly with the development of new molecular technology there is now the 
potential to use next generation sequencing (NGS) for the detection of 
microbes in equine samples. In clinical trials identifying bacteraemia-caused 
sepsis in human patients NGS identification was successful in identifying 
high levels of bacterial DNA fragments allowing for detection of Gram 
positive and Gram negative bacteria from blood samples in around 30 hours 
(Grumaz et al., 2016). This NGS diagnostic approach that provides high 
quality results from patient blood samples, could easily be introduced into 
veterinary medicine, with NGS providing a non-invasive and rapid 
diagnostic method that could be incorporated into equine diagnostics 
(Grumaz et al., 2016; Van Borm et al., 2015). Since its development, the 
price of NGS has continued to drop, allowing its consideration as a price 
effective option for veterinary medicine due to the noted high throughput 
and the capacity to generate high levels of information useful for routine 
diagnostics (Van Borm et al., 2015). It is being applied to veterinary 
medicine for the detection of infectious disease, and has the potential to 
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revolutionise detection and understanding of infectious diseases. However, 
this technology is not currently widely used within commercial laboratories 
due to the requirement for expertise and the price for equipment and 
reagents, which remains higher than currently available methods (Van Borm 
et al., 2015). The continued advances in molecular biology have the 
potential to increase diagnostic capabilities and the health and welfare 
involved with animal husbandry and infection management. It is an area that 
should be continually investigated and implemented into diagnosis as the 
technology evolves and cheapens over time (Cunha & Inácio, 2015). Using 
NGS also allows us to explore the microbiome of equines, which in a 
diseased state can differ significantly (Costa et al., 2012). Further 
exploration of normal and diseased microbiota provides a unique and 
detailed diagnostic method, particularly in the detection of gastrointestinal 
pathogens which may occur in pathogenic and commensal states (Costa & 
Weese, 2012). Current microbiome disease research by Costa et al. (2012) 
has demonstrated changes of relative abundance of Fusobacteri, 
Actinobacteria, and Spirochaetes within the gut in association with colitis. 
Of particular interest there is suggestions that some horse’s microbiota 
leaves them more susceptible to gastrointestinal disease, providing another 
avenue for future research (Julliand & Grimm, 2016).   
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5 Chapter Five 
FUTURE EXPERIMENTS AND 
RECOMMENDATIONS 
  
Despite showing the potential of PCR as a standalone diagnostic test, due to 
limitations on the clinical samples received it was not possible to completely 
investigate the trends of equine infectious disease within New Zealand. It 
was possible to identify infectious microbes within clinical samples, 
however the information collected was not sufficient to be used as proof of 
common, temporal, or significant infection types present in New Zealand 
horses. Additionally, with a staggered and gradually broadened sample 
collection and mix of sample types it was difficult to subject each sample to 
the same strict diagnostic criteria. Therefore, it cannot be said with certainty 
the absolute cause of infection, but the information could be used to guide 
treatment within a veterinary setting.  
 
With long term collection of samples overtime and standardisation of testing 
it would be possible to obtain sufficient information to develop a broad 
understanding of infection trends within New Zealand horses among 
different age groups, conditions, and temporal stages. Below are a number 
of considerations for future study design.  
 
 
5.1 Extended sample collection 
Determining trends and causes of infection in horses is an important part of 
equine diagnostic development. With sufficient information about 
mechanisms and trends of infection there will be better guidance allowing 
more accuracy with primary treatments while waiting for information from 




5.1.1 Collection of temporal samples 
It is known that the causes of infections can vary throughout the year, and 
these temporal changes can have significant effects on routes of treatments 
required due to differences in infectious pathogens. Collecting samples 
through an entire year would allow diagnostic information to be obtained for 
analysis of the temporal trends observed, which can then be used for 
subsequent first lines of treatment.  
 
 
5.1.2 Analysis by age groups 
Analysis of trends of infection in varying age groups may also provide 
substantial information that can guide future treatment in horses. By 
obtaining sufficient samples across all age groups, it would be possible to 
identify potential links between age or development status, and the potential 
risk of certain types of infection. This level of analysis can again guide the 
first line of treatment, reducing the risk of applying the wrong treatment 
while waiting for diagnostic support from PCR or cultures. 
 
 
5.1.3 Expand primer range 
Biosecurity within the New Zealand equine industry is strict, however the 
industry is still vulnerable to infection from non-endemic pathogens. Equine 
influenza is abundant in many countries, but it is yet to affect New Zealand. 
By designing and incorporating primers for high risk pathogens such as 
equine influenza into established PCR detection processes it would be 
possible to screen for high biosecurity risks before infections spread.  
 
 
5.2 Standardisation of methods 
During the course of this investigation, there was no time to standardize the 
methodology of sample reception, DNA extraction, and PCR. Solidified and 
standardised methods are important for reproducible and reliable results that 
would allow this methodology to be readily incorporated into a diagnostic 
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facility with ease. Standardised methods could be achieved through 
experimenting with multiple DNA extraction methods to determine a single 
method that provided sufficient DNA quantity and purity for each sample 
type. Additionally, by outlining clear procedures for each sample group 
diagnosis could be achieved on a large scale by firstly extracting the DNA 
from all samples with the same methodology, and then a flow through to a 
standardised PCR tests for each sample division. By further altering PCR 
conditions and reagents it may also be possible to optimise all reactions to 
work to sufficient quality within one machine with a single PCR programme.  
 
 
5.3 Multiplex PCR  
The development of multiplex PCR across all sample groups also has the 
potential to increase the ease of a standalone PCR diagnostic system. By 
optimising multiplex reactions for each sample group it would be possible to 
further decrease the time required for molecular diagnosis, and likely reduce 
error rates that may occur during PCR from pipetting error resulting in false 
negatives. Multiplex PCR assays have been successfully developed for the 
detection of bacteria and virus in humans following optimisation. The use of 
nested primers, and enzymes were tested to increase specificity of multiplex 
PCR and were found to produce positive results, however, nested PCR 




qPCR is a molecular procedure based on PCR that uses fluorescent tags to 
produce quantitative and real-time results, allowing the identification of 
amplification faster, and with higher sensitivity when compared to 
conventional PCR (Deepak et al., 2007). The use of fluorescence allows fast 
detection of low levels of DNA, such as that in some clinical samples, and 
has demonstrated utility in the detection of virus, bacteria, and fungi in 
various clinical samples (Deepak et al., 2007). Through the use of qPCR it 
is possible to quantify the levels of amplified bacterial genes, and therefore 
detect the presence of over colonised pathogens within the gut which may 
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be seen as normal. Detection of pathogens within gastrointestinal infection 
using regular PCR is inhibited by the inability to detect changes to regular 
gut flora, and there is an inability to detect changes such as over 
colonisation by a single bacteria that may cause gastrointestinal infection.   
 
qPCR technology has been utilised for the detection of specific pathogens in 
equine samples with high rates of success. Pusterla et al. (2010) utilised 
qPCR for the detection of Salmonella using the invA gene with 100% 
success rate in the 40 clinical samples, demonstrating the potential of qPCR 
as an accurate and rapid method of pathogen identification. 
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6 Chapter Six 
CONCLUSIONS 
 
The aim of this investigation was to determine the efficacy of PCR as a 
diagnostic tool for the identification of microbial infection in horses. PCR 
was found to be effective at detecting bacteria, fungi, and viruses associated 
with equine infection rapidly and was a reproducible methodology within a 
variety of sample types. The DNA based approach of PCR allowed for the 
identification of microbes from multiple sample types, proving successful in 
identifying pathogens in blood, faecal, respiratory, pus, and synovial fluid 
samples.  
 
Identification rates from sterile samples with PCR were 87%, compared to 
genus level identification from traditional culturing methods at 46.1%. PCR 
also demonstrated higher sensitivity compared to cultures, allowing 
identification of pathogens from samples following empiric antibiotic 
therapy. PCR diagnosis was also faster than bacteriological culturing (6 
hours vs 48 hours).  
 
Despite small sample sizes retrieved from this project it is still possible to 
make estimates about prevalent pathogens affecting the New Zealand 
Equine Industry. The pathogens recorded from this project did align with 
those previously reported in the NZ equine literature. 
 
A number of improvements can be made to the molecular methodology to 
increase throughput, reproducibility, and reduce error rates. Regardless of 
this, PCR has the potential to increase diagnostic efficiency, comparable to 
traditional culturing techniques increasing the health and welfare involved 
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7 Appendix One 
SOLUTIONS AND MEDIA 
 
1. DNA Extraction Solutions 
 
Plant CTAB (Used for faecal extractions) 
• 5ml 1M Tris, pH 8.0 
• 2ml 5mM EDTA 
• 1.0g CTAB 
• 4.15g NaCl 
• 1.0g PVP-40 
• 0.0445g DEICA 
• 0.5ml 2-Mercaptopethanol 
 
SDS Lysis 
• 5ml Tris 
• 5ml EDTA 
• 5ml SDS 
• 0.1ml NaCl 
 
Lithium Chloride  
• 10.6G LiCl 
• Make up to 50ml with MQ water 
 
10% CTAB  
• 0.79g Tris-HCl 
• 4.09g NaCl 
• 0.37g EDTA 
• 1g CTAB 







• 0.079g Tris-HCl 
• 0.019g EDTA 
• Make up to 50ml with MQ water  
• Adjust pH to 8.0  
 
PEG/KOH 
• 27 ml Polyethylene glycol (PEG) 200 (Sigma) 
• 465 μl 2M KOH (Riedel-de Haën) 
• Make up to 50 ml with MQ water 
• Adjust pH to 13.3-13.5 
 
Na isopropanol  
• 5.5ml 2M NaOH 
• 0.25ml 5m EDTA 
• 35ml Isopropanol 
 
Viral extraction mix (GITC) 
• 31.9g GITC in 20ml H2O 
• 9.55g GuHCl 
• 6.0g Urea  
• 0.35g of INCI  
• 0.368g Na3C6H5O7  
• 1.0ml 2-Mercaptoethanol 
 
2. Agarose Gel Electrophoresis solutions 
 
Super Buffer (50x)  
• 8g NaOH 
• 45G Boric Acid 





Super Buffer (1x)  
• 40ml 50x Super Buffer 
• Bring to 2 litres with MQ water 
 
2% Super Buffer Agarose Gel 
• 0.800g of HydraGene LE Agarose 
•  40ml 1x Super Buffer  
• Add 3µl dilute EtBr (10mg/ml H2O)  
 
DNA loading buffer (6x)  
• 3mL 30% (v/v) Glycerol 
• 25mg 0.25% (w/v) Bromophenol Blue 
• 25mg 0.25% (w/v) Xylene Cyanol FF 
• Make up to 10ml with MQ water 
 
Genscript ready to load 100bp molecular weight ladder - Ready to load 








Solis BioDyne 100bp DNA Ladder - Ready to load (0.1µg/µl) forming 13 
discrete bands with a size of 100-3,000 bp. 3µl loaded in a 2% gel. 
 





Columbia broth  
• 35g of Columbia broth media 
• 1 litre demineralised water 
• Heat to boiling to dissolve media 
• Aliquot 5ml into a 25ml culture flask 
• Sterilize at 121°C for 15 minutes 
 
Blood Agar Plates (10% sheep blood) 
• 400ml of DEPC water 
• 20.4g Columbia blood agar (Difco) 




Amikacin Agar Plates 
• 40µl per 500ml Amikacin (250mg/ml stock)  
• 400ml of DEPC water  
• 20.4g Columbia blood agar (Difco) 
• 50ml sheep blood 
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8 Appendix Two 
PRIMERS AND PCR REAGENTS 
 
Primers 
Primers were obtained from IDT or Sigma Aldrich. Tubes were centrifuged 
at 16,600g for 10 seconds and resuspended in TE buffer following 
manufacturer’s directions to a concentration of 200µM or 100µM. Stock 
solution was divided into 20µL aliquots and frozen at -20°C until required. 
 
20µM working stock primers 
10µl of forward primer (200µM) and 10µl of reverse primer (200µM) were 
combined in a 0.6ml DNase/RNase free microcentrifuge tube and diluted 
with 80µl TE buffer and stored at 4°C to be used as primers for working 
stock.  
 
10µM working stock primers 
10µl of forward primer (100µM) and 10µl of reverse primer (100µM) were 
combined in a 0.6ml DNase/RNase free microcentrifuge tube and diluted 




Degenerate primers bases and non-standard bases 
Some primers were degenerate or used non-standard bases. Listed dictates 






I Inosine  
B C or G or T 
R A or G 
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N A or C or G or T 
D A or G or T 
 
 
2mM PCR master mix 




10x Buffer B1 1x 20µl 
MgCl2 (25mM) 2mM 16µl 
dNTP mix (20mM each) 0.25mM 2.5µl 
 
4mM PCR master mix 




10x Buffer B1 1x 20µl 
MgCl2 (25mM) 4mM 32µl 









DNA sequencing of PCR products was carried out during this project to 
determine the accuracy of microbial primers. In addition to BLAST analysis, 
electropherogram reports were examined to confirm the accuracy of the 
actual sequencing and confirm the primers were suitable for diagnostic 



















































































































Figure A3.13: High quality electropherogram output from R. equi (VAP) DNA sequencing of sample S023. 




















































Figure A3.19: 137bp fragment from position 4,794 – 4,931 of Equus przewalkskii tescalcin gene (NCBI accession: XM_008515476.1) mapped to R. equi 








Figure A3.20: Alignment of vapA primers to Equus przewalkskii tescalcin gene (NCBI accession: XM_008515476.1) showing approximately 50% similarity. 
Amplified PCR product from sample S015 is shown in bold. Complimentary forward and reverse PCR primers for vapA are shown in yellow highlight. 
